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ABSTRACT 
Muscle weakness is the most common and persistent problem after a critical illness. Early 
mobilization of the critically ill patient, beginning with passive exercise and progressing to 
ambulation, may mitigate muscle effects of the critical illness. However, mobilization may 
produce adverse effects, especially early in the illness when risk for physiologic deterioration is 
common. If safe, introducing a mobility intervention early in the illness may facilitate ventilator 
weaning, shorten intensive care unit and hospitals stays, and improve functional status and 
quality of life for mechanically ventilated critically ill patients.  
The aim of this study was assess the cardiopulmonary and inflammatory responses to an 
early standardized passive exercise protocol (PEP) in mechanically ventilated critically ill 
patients. Using a quasi-experimental within-subjects repeated measures design, mechanically 
ventilated critically ill adults who were physiologically stable received a single standardized PEP 
within 72 hours of intubation. The PEP consisted of 20 minutes of bilateral passive leg 
movement delivered by continuous passive motion machines at a rate of 20 repetitions per 
minute, from 5-75 degrees, to simulate very slow walking. Physiologic parameters evaluated 
included heart rate (HR), mean blood pressure (MBP), oxygen saturation, and cytokine levels 
(IL-6 and IL-10), obtained before, during, and after the intervention. The Behavioral Pain Scale 
(BPS), administered before, during and after the intervention was used as a measure of 
participant comfort.  
The study sample was comprised of 18 (60%) males and 12 (40%) females, with a mean 
age of 56.5 years (SD 16.9 years), who were primarily Caucasian (N=18, 64%). Mean APACHE 
II scores for the sample were 23.8 (SD 6.2) with a mean predicted death rate of 48.8 (SD 19.8), 
indicating moderate mortality risk related to illness severity. Number of comorbidities ranged 
iv 
from 1-10 (X=4). All participants completed the intervention with no adverse events. Using 
repeated measures analysis of variance (rmANOVA), no significant differences were found in 
HR, MBP, or oxygen saturation at any of the four time points in comparison to baseline. BPS 
scores were significantly reduced (F(2.43, 70.42)=4.08, p=.02) at 5 and 10  minutes after the 
PEP was started, and were sustained at 20 minutes and for one hour after the PEP was 
completed. IL-6 was significantly reduced (F(1.60, 43.1)=4.351, p=.03) at the end of the 
intervention but not at the end of the final rest period. IL-10 values were not significantly 
different at any of the three time points, but IL-6 to IL-10 ratios did decrease significantly 
(F(1.61, 43.38)=3.42, p=.05) at the end of the PEP and again after a 60 minute rest period.  
Passive leg exercise was well tolerated by study participants. HR, MBP, and oxygen saturation 
were maintained within order set-specified ranges during and for one hour after activity, and 
patient comfort improved during and after the intervention. A downward trend in HR was noted 
in participants, which is contrary to usual HR response during exercise, and may represent 
clinical improvement in this population related to reduction in pain. Reduction of mean IL-6 
values at the end of the PEP, but not after the rest period, suggests that the PEP was responsible 
for the initial IL-6 improvement.  Improvement of IL-6 to IL-10 ratios from the end of the PEP 
to the end of the final rest period suggests that IL-10, although non-significant, may have had 
some effect, indicating that IL-10 increases may occur later than the time period of study. 
Passive exercise can be used as an approach to facilitating mobilization in mechanically 
ventilated critically ill adults until they are ready to participate in more active exercise. It could 
be that more frequent and aggressive exercise, such as passive cycling at faster rates, four times 
daily, will be tolerated in this population. While the understanding of clinical significance of 
cytokine profiles in critically ill patients is still evolving, cytokine levels may be useful in 
v 
explaining benefits of mobilization in this population. Further study is required to replicate the 
impact of passive exercise on pain, and it may represent a novel approach to pain management in 
critically ill patients.  
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CHAPTER ONE: INTRODUCTION 
Muscle weakness is the most common complication of critical illness, as well as the most 
persistent problem after a critical illness.
1
 Fatigue, poor functional status and decreased health-
related quality of life one year after a critical illness are all attributed to persistent muscle 
weakness.
4
 The muscle weakness associated with critical illness is due to immobility as well as 
inflammation.
3
 Inflammation diminishes both muscle mass and strength. Inflamed muscle is 
problematic in that it can prolong need for mechanical ventilation, extend hospital stay, and 
complicate recovery, as well as negatively impact quality of life for the individual with critical 
illness.
4
 Mobilization is one approach to mitigating inflammation and muscle weakness after a 
critical illness.
5
 It covers a wide range of progressive activities, from passive and active range of 
motion (ROM), to dangling, standing or lift transfer to a chair, and ambulation.
1,6,7
 Mobilization 
is thought to preserve muscle strength and mass by improving blood flow, stimulating anti-
inflammatory cytokine production and enhancing insulin activity and glucose uptake in muscle.
3
 
Mobilization has been shown to improve outcomes for critically ill adults.
1,8
 Improved 
outcomes include earlier ambulation, shorter lengths of intensive care unit (ICU) and hospital 
stays, and improved functional status as well as quality of life.
1,2,8
 Whether a decrease in 
inflammation could be directly attributed to activity and improved outcomes is not yet known, 
but preliminary evidence suggests that 20 minutes of sustained activity daily can improve 
cytokine profiles in critically ill patients.
9
 
Mobilization protocols, beginning with passive activity and advancing to ambulation, 
have been studied as a step-wise approach to activity progression but many study participants 
have been unable to move beyond passive activity.
1, 8 
Primary reasons for failure to progress 
were decreased responsiveness and physiologic instability.
1, 6, 8
 Physiologic instability in 
 2 
mechanically ventilated critically ill patients may persist for days to weeks, delaying use of 
active mobility interventions. Passive exercise, a routine nursing procedure, may be the most 
appropriate activity for these patients in the early phase of illness.
10
 However, limited empirical 
evidence exists to support the safety or efficacy of passive activity, particularly during periods of 
physiologic instability, and criteria to document readiness to institute active mobilization have 
not yet been developed. Tolerance of passive activity may be one signal that progression is 
appropriate. 
Patient tolerance appears to be the limiting factor in application of mobilization 
activities.
10,11
 Commonly used bedside physiologic measures, such as heart rate and blood 
pressure, have been suggested as approaches to identifying patient tolerance,
6, 11
 and preliminary 
research has demonstrated physiologic stability in mechanically ventilated critically ill patients 
who were mobilized 5 days or longer after intubation.
12
 However, waiting to start mobilization 
for 5 days or longer after intubation may miss an important window of opportunity to improve 
patient outcomes. Loss of muscle mass and strength is evident soon after critical illness onset; 
2% of mass may be lost within the first 24 hours of critical illness.
3,10
 With muscle changes 
appearing soon after onset of critical illness,
13
 it is logical to consider implementation of 
mobilization soon after illness onset, as delay may add to disability.
14
  
Concern has been expressed about early mobilization contributing to increased muscle 
inflammation, which may actually compound rather than prevent muscle weakness.
15
 
Inflammatory markers did not change significantly with passive activity (< 15 min), suggesting 
that passive activity does not increase inflammation.
16
 However, further study would add to 
safety support for this measure.  
 3 
To date, limited study has been done to evaluate safety of passive activity in early critical 
illness. Chapter 2 provides a review of the state of the science related to passive activity in 
critical illness. Passive activity, if demonstrated to be safe, may provide early benefit to those 
critically ill patients who are not yet able to tolerate progressive activity. Introducing a 
mobilization intervention early in the illness may facilitate weaning, shorten intensive care unit 
and hospitals stays, and improve quality of life for mechanically ventilated critically ill patients. 
Study Purpose and Aims 
The aim of this study was to assess the physiologic responses to a standardized passive 
exercise intervention instituted within 72 hours of intubation in mechanically ventilated critically 
ill patients. The specific research questions asked were: 
1. What is the cardiopulmonary response to an early passive exercise protocol (PEP) in 
mechanically ventilated critically ill patients? 
2. What is the intracranial pressure (ICP) response to an early passive exercise 
protocol (PEP) in mechanically ventilated critically ill patients? 
3. What is the behavioral pain response to an early passive exercise protocol (PEP) in 
mechanically ventilated critically ill patients? 
4. What is the inflammatory response to an early passive exercise protocol (PEP) in 
mechanically ventilated critically ill patients? 
Theoretical Framework 
The muscle weakness associated with critical illness is thought to be due to inflammation 
rather than immobility. A theoretical framework focused on inflammation is relevant to the study 
of critical illness myopathy, as it provides a more rational explanation for the muscle weakness 
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that occurs with critical illness than immobility alone. In muscle that has been immobilized, 
myosin filaments are typically retained while actin fibers are lost, leading to significant loss in 
mass and but not strength.
5
 In contrast, inflamed muscle has been observed to lose both myosin 
and actin,
5
 supporting the concept that inflammation plays a significant role in muscle weakness. 
Critical illness typically invokes a systemic inflammatory response.
17
 Muscle weakness in 
critical illness represents a type of organ failure secondary to this systemic inflammatory 
response.
5
 The systemic inflammatory response is thought to affect the muscle as follows. 
Catecholamines released during the inflammatory response bind to muscle cell receptor 
sites to stimulate muscle proteolysis. The protective purpose of proteolysis is to provide readily 
available amino acids for gluconeogenesis. High catecholamine levels not only contribute to 
muscle protein loss, but also can also suppress protein synthesis through cytokine mechanisms.
18
 
Catecholamines upregulate the expression of the pro-inflammatory cytokines, IL-1 and tumor 
necrosis factor-alpha (TNF-a), which can have adverse effects on muscle. TNF-a affects muscle 
regeneration by inactivating a muscle proliferation transcription factor,
19
 which ultimately 
decreases protein synthesis, resulting in decreased muscle mass. Concomitantly, IL-1a generates 
free radicals, which damage myosin filaments, resulting in decreased strength.
18,19
 TNF-a also 
reacts with muscle receptors that block aerobic protein metabolism, thereby creating oxidative 
stress in the muscle, ultimately decreasing contractility.
19 
IL-1 activates IL-6, which has both pro- and anti-inflammatory effects. IL-6 stimulates 
neutrophil maturation and natural killer (NK) cell differentiation, but it also promotes release of 
anti-inflammatory cytokines and downregulates IL-1 and TNF-a over time.
19
 Muscle cells have 
receptors for IL-6; those IL-6 receptors are thought to contribute to muscle proteolysis by 
recruiting infiltrative inflammatory products such as prostaglandins.
19
 Muscle cells also express 
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IL-6, and this expression is thought to be linked to the glucose metabolism that is necessary for 
energy production and muscle repair.
19
 In a homeostatic state, IL-6 activates IL-10, which 
mediates effects of IL-1, IL-6 and TNF-a, thus protecting muscle. Sustained production of pro-
inflammatory cytokines can suppress anti-inflammatory cytokines.
19
 Imbalance of pro- and anti-
inflammatory cytokines is thought to contribute to muscle breakdown and impairment of repair 
mechanisms that characterizes the muscle weakness seen in critical illness.
20
  
Systemic inflammation also produces cytokine-mediated microcirculatory changes. IL-1 
increases endothelial adhesion of lymphocytes through activation of cell adhesion molecules, a 
process designed to prevent microbial invasion. As cells adhere, thrombosis of microcirculation 
and consequent muscle ischemia and micro-infarction can occur.
21
 Tissue hypoxia upregulates 
IL-1 and TNF-a expression, compounding the process. Capillary permeability is also increased 
in the inflammatory response, due to expression of IL-1b, which stimulates release of 
prostaglandins. The resulting vascular permeability may allow greater exposure of muscle cells 
to cortisol. Cortisol is implicated in what has been termed an “acquired channelopathy,” in which 
cortisol binding on muscle receptor sites dysregulates the sodium channels, resulting in 
decreased excitability of the muscle.
18
  
Hyperglycemia is an additional factor in muscle damage. The relative insulin resistance 
produced in response to increased cortisol levels can exacerbate muscle catabolism.
5, 18, 19
 Insulin 
has been found to play an important role in preventing muscle proteolysis as well as promoting 
muscle repair. Maintenance of normoglycemia may protect muscle.
22 
Prevention of muscle weakness in critical illness focuses on decreasing inflammation, 
promoting blood flow, and restoring normoglycemia.
22
 Mobilization activities may produce all 
three benefits, and even passive activities may provide some muscle protection (Figure 1).  
 6 
 
 
Figure 1. Interactions of inflammatory responses on muscle metabolism. Note that IL-1, IL-6, 
and TNF-α act as mediators for the inflammatory cascade. Not depicted here is the action of IL-
10. As an anti-inflammatory cytokine, IL-10 is activated by IL-6 to mediate (downregulate) 
expression of IL-1 and TNF-α, in effect inactivating the inflammatory response.  
 
Pedersen and Hoffman-Goetz suggest that activity and exercise stimulate release of 
inhibitory factors that decrease or turn off the inflammatory response.
23
 The inhibitory factors are 
IL-1ra, which blocks IL-1 activity, and IL-10 which provides anti-inflammatory balance to the 
pro-inflammatory IL-6. Thus, activity mediates the magnitude and duration of the inflammatory 
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response.
23
 Activity has been noted to increase pro-inflammatory cytokines, specifically IL-
6.
23,24
 However, the increase in IL-6 appears to be related to intense, prolonged exercise which 
typically would not be expected in the critical care setting. Similarly, decreased activity 
tolerance, which is anticipated in the critical care setting, has also been associated with an 
increase in IL-6.
23
  Further evidence suggests that the IL-6 may be muscle-derived rather than 
circulating IL-6, which may actually contribute to muscle repair and protection.
20,24
 Muscle 
activity has also been purported to reduce small vessel compression and improve blood flow 
which may reduce inflammatory factors present in the muscle.
24
 Low resistance exercise, 
including passive or active range of motion, has been found to increase muscle blood flow and 
oxygen supply. Continuous passive exercise in one leg three times a day for seven days 
improved muscle blood flow and prevented myopathy in the treated leg in 5 critically ill 
patients.
25
 Exercise also decreases insulin resistance,
24, 26
 which may modulate the effects of 
hyperglycemia on muscle.  
The inflammation framework provides multiple defined targets for intervention. The 
physiologic responses in the framework serve as measurement points that may be used to 
determine safety or efficacy of targeted interventions.  The framework also crosses disciplines, 
so its utility is not limited to nursing alone. The major limitation in using this framework is that 
inflammation is a systemic response, not limited to muscle. It is feasible that other systemic 
effects may intervene, limiting therapeutic effects of any targeted interventions. In addition, the 
immune system focus limits additional factors, such as psychological stress, from contributing to 
outcomes. 
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Physiologic Responses to Passive Activity 
Identifying safety and feasibility of a passive exercise intervention is a crucial first step in 
adopting prescribed mobilization into the multidisciplinary plan of care for a critically ill patient. 
This research study sought to provide safety and feasibility support in advance of a larger study 
that would evaluate efficacy of a progressive exercise intervention in critically ill patients.  
Following Institutional Review Board approval and after obtaining proxy consent, 30 
mechanically ventilated critically ill adults from three intensive care units (neuroscience, 
multisystem, and trauma) in one tertiary care center were enrolled in the study. Following a rest 
period, participants underwent a 20 minute passive exercise protocol followed by an additional 
rest period. Physiologic variables, including heart rate, blood pressure, oxygen saturation, 
intracranial pressure, cytokine levels, and behavioral pain response, were monitored at specified 
time points throughout the study. Details of the study and its findings are found in Chapter 3. 
Measurement of physiologic responses to mobilization presents several unique challenges 
in the critical care setting. The ability to replicate study findings and apply results to practice 
requires the selection of optimum variables to measure, appropriate timing of variable 
measurement, and adoption of approaches to assuring precision and accuracy in measurement.  
Issues related to measurement of physiologic variables appropriate for this study and setting are 
addressed in Chapter 4. 
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CHAPTER 2: LITERATURE REVIEW 
Abstract 
Muscle weakness is the most common and persistent problem after a critical illness. Early 
mobilization of the critically ill patient, beginning with passive exercise and progressing to 
ambulation, may mitigate muscle effects of critical illness. Although mobilization is quickly 
being incorporated into care for critically ill patients, standards for mobilization interventions are 
lacking. To identify evidence supporting timing and type of mobilization interventions for 
critically ill patients, a comprehensive literature search of electronic databases was conducted 
from 1990 to present, including CINAHL, MEDLINE the Cochrane Database of Systematic 
Reviews, and PubMed. Search terms used were mobilization, exercise, activity, and critical 
illness. Fifteen articles were identified for review. The analysis focused on what constitutes 
mobilization, which patients should receive it and when, and who should provide mobilization 
interventions.   
The analysis revealed that a “toolbox” of mobilization activities is available to the 
bedside practitioner but specific guidelines for how and when to implement those activities are 
limited.  Although early mobilization is advocated in literature, clear definition of “early” was 
lacking. Strict study inclusion criteria limited patient involvement in mobilization activities. 
Several different practitioners delivered mobilization interventions but most protocols were 
driven by physical therapists rather than nurses, although a team approach was advocated. 
Knowledge that supports decisions about how and when to mobilize critically ill patients is 
evolving. Comparing study outcomes is challenging with treatment routines varying so 
widely. Clinical trials that incorporate progressive mobilization across broad population of 
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critically ill patients are needed, along with studies that demonstrate that mobilization protocols 
can be implemented into practice at the bedside. 
Introduction 
Muscle weakness is the most common and persistent problem after a critical illness.
1
 
Fatigue, poor functional status and decreased health-related quality of life one year after a critical 
illness are all attributed to persistent muscle weakness.
2
 Muscle weakness associated with critical 
illness cannot be explained by immobility alone. The inflammatory response resulting from the 
physiologic stressors of critical illness has been identified as a major contributor.
3,4
 The 
inflammatory cascade of events that occurs consequent to critical illness has wide-reaching 
effects, well beyond the organ system affected by the illness, and muscle is only one organ of 
many that are affected.
4
 Inflammation diminishes both muscle mass and strength. Inflamed 
muscle is problematic in that it can prolong need for mechanical ventilation, extend hospital stay, 
and complicate recovery, as well as negatively impact quality of life for the individual with 
critical illness.
5 
Mobilization is a progressive, interdisciplinary, goal-directed therapy that has been 
proposed as one approach to mitigate the muscle weakness after a critical illness.
6-8
 Mobilization 
is thought to improve blood flow, stimulate anti-inflammatory cytokine production and enhance 
insulin activity and glucose uptake in muscle,
4,9
 all of which may serve to preserve muscle 
strength and mass. Physical activity is also thought to reduce pain, decrease anxiety, improve 
delirium, promote sleep, and improve mood, all of which are beneficial in reducing effects of 
illness on muscle.
10,11
 Recent studies have documented improvements in functional status and 
fewer ventilator and hospital days when mobilization was implemented into the plan of care.
12,13 
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Although mobilization is quickly being incorporated into care for critically ill patients, standards 
for mobilization interventions are lacking. A critical analysis of current literature on mobilization 
in the critical care setting was conducted, with a focus on what constitutes mobilization, which 
patients should receive it and when, and who should provide these interventions. Results from 
this analysis may be used to develop evidence-based interventions in the future as well as direct 
research for mobilization interventions in critically ill patients. 
Review of the Literature 
A search of the literature was conducted using the search terms, mobilization, exercise, 
activity, and critical illness to identify studies that evaluated mobilization interventions in 
critically ill patients. Table 1 provides operational definitions for these terms.  
 
Table 1. Operational Definitions. 
Term Operational Definition 
Mobilization A goal-directed interdisciplinary therapy that involves a variety of 
activities (on a continuum from passive to progressively active activities). 
Activity Movement in a patient initiated by the patient or an individual other than 
the patient, and without active resistance. 
Exercise Movement in a patient with a specified duration, intensity and frequency.  
Passive exercise without resistance, initiated by an individual other than 
the patient may include passive range of motion, passive cycle 
ergometry, and neuromuscular electrical stimulation. Active exercise, 
initiated by the patient or an individual other than the patient, may 
include active range of motion, sitting, standing, active cycling and 
walking. 
Critical illness Illness of sufficient severity that requires mechanical ventilation and/or 
care in an intensive care unit. 
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CINAHL, MEDLINE, the Cochrane Database of Systematic Reviews, and PubMed 
databases were examined from 1990 to 2012. Studies published from 1990 forward were 
considered in an effort to reflect current practices; 170 articles were identified that met search 
criteria. To be included in the final review, articles met the following criteria: 1) published in the 
English language, and 2) incorporated mobilization as an intervention in a critically ill (acute or 
chronic) sample, or 3) evaluated practitioner mobilization practices. Articles excluded from the 
review were those that were reviews only (109 excluded), addressed mobilization after resolution 
of the critical illness (29 excluded), were non-interventional studies (5 excluded) or written in a 
language other than English (12 excluded). Upon selection, articles were reviewed for 
descriptions of mobilization interventions, inclusion and exclusion criteria; when those 
interventions were implemented within the patient’s illness trajectory; and which practitioners 
were involved in the implementation. Fifteen articles were found that met inclusion criteria for 
this review. Table 2 summarizes evidence found in the 15 articles. 
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Table 2. Summary of Mobilization in Critical Care Evidence. 
Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
Bailey, 
Thomsen, 
Spuhler, Blair, 
Jewkes, 
Bezdjian, et al., 
2007 
Determine 
whether physical 
activity was safe, 
feasible in resp. 
failure patients 
103, M>F, 63 
years mean age; 
48% > 65 yrs of 
age 
Required MV for 
>4 days 
Responding to 
verbal stimuli 
FiO2 < .6, PEEP 
< 10 cmH20 
(relative) 
Absence of 
orthostatic 
hypotension 
No 
catecholamine 
drips (relative) 
Required MV for 
<4 days, 
Coma 
Stabilization 
through ICU stay 
(mean time to 
dangle 6.6+5.5 
days; sit 
11.3+10.1 days; 
walk 12.4+10.7 
days) 
Twice daily 
intervention 
Pre and post 30 
assist-control 
rest period 
Increased .2 FiO2 
before activity 
Progressive 
dangle, sit, 
ambulate 
O2 saturation (> 
80%) 
BP (systolic 90-
200 mmHg) 
Adverse events 
Ventilator data 
Hospital 
disposition 
17% died; 33% 
home 
Duration MV 
18.7+15.4 days 
ICU LOS 
22.7+15.9 days 
Hospital LOS 
26.6+17 days 
No difference in 
>65 vs < 65 
Adverse events 
occurred in .96% 
of activity 
events; did not 
prolong stay or 
increase costs 
 
2.4% unable to 
tolerate activity 
at all 
12% unable to 
complete some 
scheduled 
activities 
Did not require 
increased 
staffing 
Concluded to be 
safe and feasible 
No control group 
Bourdin, 
Barbier, Burle, 
Durante, 
Passant, et al., 
2010 
To determine 
whether early 
activity in 
critical care 
setting is feasible 
and safe, and 
potential benefits 
20 (13 before 
extubation, 7 
after) 
MV > 2 days, 
ICU at least 7 
days 
Agitation, 
confusion, 
comatose; 
SBP < 90; 
vasopressors;  
paO2/FiO2 ratio 
< 200; paCO2 > 
50; pH < 7.2; 
CRRT; IV 
sedation 
Twice daily 
intervention 
beginning mean 
day 5 
Chair sitting, tilt 
table, walking 
(mean durations 
were 150 min, 
15 min, and 10 
min 
respectively) 
HR (<130 or 
within 20% or 
baseline); 
RR (<35 or 
within 20% of 
baseline); O2 
saturation 
(>88%); SBP 
(>90 or <180) 
Adverse events MV mean 
duration 7 days; 
ICU LOS 17 
days 
Improved O2 
saturation with 
chair sitting 
Adverse events 
in 3%; no 
clinical 
consequences 
43% were unable 
to receive 
interventions as 
scheduled 
Understaffing 
limited second 
episode during 
the day 
Burtin, Clerckx, 
Robbeets, 
To determine 
whether early 
90, mean age 59 
years 
Cardiorespirator
y instability 
Day 5 or longer  
Randomized to 
Passive activity 
to ambulation in 
HR (>70% PM 
or > decrease), 
SF 36 
6MWD 
Decreased O2 
saturation 
Drop outs older 
Sedation and 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
Ferdinande, 
Langer, et al., 
2009 
passive exercise 
can improve 
function in 
critically ill 
compared to 
physical therapy 
Eligibility 
determined by 
intensivist 
Anticipated MV 
> 7 days 
(only 15% of 
prolonged MV 
eligible) 
 
control or 
treatment  
Mean enrollment 
day 10 in control 
group and day 14 
in cycling group 
Daily 
intervention 
both groups 
Additional 
cycling 20 
minutes, 20 
cycles/min; 
increased 
resistance if 
active (55% 
passive on 
initiation; 13% 
unable to 
progress to 
active) 
SBP (>180 or > 
20% decrease), 
DBP (> 20% 
decrease), O2 
saturation 
(<90%), RR 
Parameters 
normalized 
within 2 minutes 
Quad Force Berg 
Scale 
Weaning Time 
LOS 
1 year mortality 
1.3+1.7% 
16 sessions 
terminated early 
due to adverse 
events 
Treatment group 
had farther 
6MWD (196 m 
vs 143 m: 
p<.05), higher 
SF- 36 (21 vs 15; 
p<.01), greater 
quad force 1.83 
vs 2.37; p=.002) 
Hand grip force 
and Berg scale  
not different 
Weaning time, 
LOS ICU, LOS 
Hospital, and 
one-year 
mortality  not 
different 
NMB greater 
and  LOS prior 
to inclusion 
longer in 
treatment group 
No clinical 
physiologic 
changes during 
cycling 
More patients 
discharged home 
Garzon-Serrano, 
Ryan, Waak, 
Hirschberg , 
Tully, Bittner, 
Chipman,  
Schmidt, 
Kasotakis, 
Benjamin, 
Zafonte, 
To evaluate 
whether 
mobilization 
practices differed 
between nurses 
and physical 
therapists 
63; 232 
mobilization 
events; all 
consecutive 
patients were 
included 
None (in order to 
not limit 
mobilization 
attempts, a phase 
O category was 
used) 
On admission A progressive 
mobilization 
protocol  
Continuous 
monitoring BP, 
HR, O2 
saturation; 
clinician 
discretion for 
phase 0 
Phase (type) of 
mobilization; 
number of 
adverse events; 
barriers to 
mobilization 
Nurses 
mobilized earlier 
than physical 
therapists; 
physical 
therapists 
mobilized to a 
greater extent 
(more active); 
Avoid strict 
exclusion criteria 
for mobilization; 
capitalize on 
different team 
member 
contributions 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
Eikermann, 2011 identified 
barriers differed 
between groups; 
nursing severity 
score predicted 
mobilization 
Griffiths. 
Palmer, 
Helliwell, 
MacLennan, 
MacMillan, 1995 
To examine 
whether PROM 
can prevent 
muscle wasting  
5; MV with 
NMB for 7 days 
MV and NMB Time from 
intubation  to 
beginning of 
therapy not 
specified; 3x 
daily while in 
ICU 
Three 3-hour 
PROM 
treatments daily 
per CPM 
machine on one 
leg; SOC to 
other leg; leg 
randomized 
NA Muscle biopsy; 
limb weight 
Fiber area 
slightly 
increased in 
treated leg (mean 
increase 11%); 
less protein loss 
in treated leg; 
treated leg 
weighed 
significantly 
more than 
untreated leg 
PROM preserves 
muscle 
architecture but 
may not prevent 
wasting 
Morris, Goad, 
Thompson, 
Taylor, Harry, et 
al., 2008 
To identify 
frequency of 
patients 
receiving PT, 
site of therapy, 
and patient 
outcomes 
330; 48 hours of 
intubation with 
MV, 72 hours of 
admission to 
ICU 
Inability to walk 
or nonverbal 
prior to 
admission, 
immune 
compromise, 
NM disease, 
stroke, BMI >45, 
unstable fracture, 
DNR, cancer 
therapy within 6 
months,  ICU 
readmission 
within 30 days, 
Daily 
intervention 
beginning within 
48 hrs of 
intubation; actual 
timing of 
intervention start 
not reported 
Block allocation 
design; 3 ICUs 
serving as 
control and 
treatment unit at 
different times 
PT as ordered 
daily (control) vs 
mobility 
protocol with 
progressive 
additive  
advance from 
PROM to active 
O2 saturation 
>88%, MAP >65 
Survivors to 
discharge who 
received PT; 
days until OOB; 
ventilator days; 
ICU LOS; 
hospital LOS 
2.3% of events 
not initiated due 
to instability 
47% of usual are 
group received 
PT while 80% 
received PT with 
mobility protocol 
(treatment group 
received more 
therapy, p<.001); 
treatment group 
OOB earlier (5.0 
days vs 11.3 
Standardized 
approach 
Only survivors 
included in data 
analysis 
No effect from 
steroids 
Average cost per 
patient less but 
not statistically 
significant 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
new arrhythmia 
cardiac ischemia 
transfer 
(treatment) 
days; p<.001); 
26.7% unable to 
progress beyond 
PROM; 7.1 
mean days at 
PROM level 
No significant 
difference in 
ventilator days 
ICU LOS shorter 
for treatment 
group (5.5 vs 
6.9; p=.025); 
hospital LOS 
shorter for 
treatment group 
(11.2 vs 14.5; 
p=.006) 
Pohlman, 
Schweickert, 
Pohlman, Nigos, 
Pawlik, et al., 
2010 
To determine 
feasibility of  a 
protocol of early 
therapy and 
sedation 
interruption in 
mechanically 
ventilated 
critically ill 
patients; to 
identify adverse 
effects and 
barriers    
49; age >18 
years; MV < 72 
hrs but expected 
at least an 
additional 24 
hrs; Barthel 
Index >70 before 
admission 
Rapidly evolving 
neuromuscular 
disease; cardiac 
arrest; 
irreversible 
condition; 
increased ICP; 
absent limbs; 
involvement in 
another trial 
Within 72 hrs of 
intubation; time 
from intubation 
to intervention 
1.5 days (1.0-
2.1) 
Daily 
interruption of 
sedation with 
therapy during 
that time; PT/OT 
screen; PROM 
of seven sets of 
joints (number of 
repetitions or 
duration not 
specified); 
progressed to 
sitting, standing, 
walking as 
MAP<65; 
HR<40, >130; 
RR<5, >40; O2 
saturation <88%; 
increased ICP; 
active GI bleed; 
active 
myocardial 
ischemia; 
insecure airway; 
device 
dislocation 
Number and 
duration of 
therapy sessions, 
types of activity 
Potential barriers 
to therapy 
Neurocognitive 
measures 
 
Therapy 
occurred on 87% 
of days of study, 
90% of days on 
MV; 81% of 
days post-ICU; 
duration 26+14 
mins while on 
MV, 28+10 mins 
while in ICU, 
28+10 post-ICU; 
85% able to 
perform AROM; 
69% dangled; 
Enrolled 49 
participants over 
26 months 
Unsure as to use 
of CAM-ICU; no 
analysis reported 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
tolerated 33% up to chair; 
15% walked 
Potential barriers 
to therapy did 
not prevent 
therapy 
Adverse events 
occurred in 16% 
of all sessions 
(498) but all 
resolved after 
stopping therapy 
CAM-ICU was 
negative in 40% 
of patients and 
positive in 53% 
of patients  
 
Schweickert, 
Pohlman, 
Pohlman, Nigos, 
Pawlik, et al., 
2009 
To determine 
whether an early 
therapy protocol 
combined with 
sedation 
interruption 
improved 
functional and 
neuro-
psychiatric 
outcomes 
104; age >18 
years; MV < 72 
hrs but expected 
at least an 
additional 24 
hrs; Barthel 
Index >70 before 
admission 
Rapidly evolving 
neuromuscular 
disease; cardiac 
arrest; 
irreversible 
condition; 
increased ICP; 
absent limbs; 
involvement in 
another trial 
Within 72 hrs of 
intubation; time 
from intubation 
to intervention 
1.5 days (1.0-
2.1) 
Randomization 
to SOC or 
protocol; daily 
interruption of 
sedation with 
therapy during 
that time; PT/OT 
screen; PROM 
of seven sets of 
joints (number of 
repetitions or 
duration not 
specified); 
progressed to 
MAP<65 or 
>110; systolic 
BP >200; 
HR<40 or >130; 
; RR<5, >40; 
pulse ox <88%; 
increased ICP; 
active GI bleed; 
active 
myocardial 
ischemia; 
insecure airway; 
ventilator 
asynchrony; new 
Functional status 
at discharge 
Number of 
hospital days 
with delirium 
(CAM-ICU) 
Number of 
ventilator-free 
days during 
hospital stay; 
length of ICU 
stay 
Adverse events 
50% achieved 
functional 
independence at 
discharge 
(Barthel >70), 
59% in protocol 
group and 35% 
in control 
(p=.02) 
In protocol 
group: less 
delirium (2.0 vs 
4.0, p=.03); 
more ventilator-
Death assigned 0 
ventilator-free 
days 
ICU stay 
approached 
significance in 
protocol group 
(p=.08); hospital 
LOS 
nonsignificant 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
sitting, standing, 
walking as 
tolerated 
arrhythmia free days (23.5 
vs 21.1; p=.05);  
therapy began at 
1.5 days in 
protocol group 
and 7.4 days in 
SOC group; 
sedation and 
analgesia the 
same between 
groups 
One desaturation 
episode in 498 
events 
Skinner, Berney, 
Warrillow, 
Denehy, 2008 
To identify 
exercise 
prescription by 
PTs for MV 
patients and 
outcome 
measures 
commonly used 
111; PTs 
working in ICUs 
in Australia; no 
returns from one 
region 
NA NA NA- 24-item 
survey of PT 
practices in ICUs 
(response rate 
75%) 
PTs identified 
O2 saturation, 
HR, RR, and 
perception of 
fatigue as safety 
measures 
necessary 
Only 34% used 
outcome 
measures; RR, 
O2 saturation, 
distance walked 
were used 
94% of 
respondents 
prescribed PT 
regularly; 42% 
indicated that PT 
should be 
performed in all 
ICU patients 
except for those 
on inotropes, 
CRRT, ARDS; 
5% thought PT 
should be 
restricted to 
those on MV; 
frequency varied 
widely; type of 
activity was 
Even 
experienced 
practitioners 
have widely 
variable 
practices; 
evidence not 
applied to 
practice 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
ROM, sit to 
stand, transfer, 
march, ambulate, 
tilt table; 
multiple factors 
were used to 
determine 
ability, 
frequency and 
duration;  
Stiller, Phillips , 
& Lambert, 2004  
To determine 
hemodynamic 
and respiratory 
response to 
mobilization of 
the critically ill 
patient 
31 participants 
receiving 69 
treatments; HR 
<50% APN; 
O2saturation 
>90%; 
paO2/FiO2> 300 
PROM and 
mechanical 
transfers 
excluded; 
extensive 
exclusion criteria 
based on medical 
condition 
3 different time 
periods to 
maximize 
variability; mean 
29 days of 
intubation at 
onset of therapy 
Progressive 
mobilization 
from dangle to 
ambulation; 
HR; HR APN; 
systolic and 
diastolic BP; O2 
saturation; 
patient 
appearance 
Number and type 
of therapies; 
change in HR, 
BP, and O2 
saturation from 
baseline 
HR and BP 
significantly 
increased with 
mobility 
(p<.001) 
increased but not 
clinically 
significant; 
decreases in O2 
saturation 
evident but not 
significant 
(p=.44); 3 
desaturation 
events required 
intervention  
19% of patients 
in the ICU 
received this 
intervention; 
83.8% received 
ROM 
Stockley, 
Hughes, & 
Rooney, 2010 
To determine PT 
passive ROM 
practices in ICUs 
in the UK 
165, 152 of 
which reported 
using PROM in 
MV ICU 
patients; 
participants 
Not working 
with ICU 
patients 
NA 12-item 
questionnaire; 
open ended, 
closed and 
matrix questions 
Monitoring 
parameters used 
were ICP, PAC, 
CVP, RR, 
HR/rhythm, BP 
O2 saturation 
Frequencies of 
therapies 
performed and 
safety 
parameters 
routinely 
PROM 
performed by all 
study 
respondents 
daily; mean 5 
repetitions per 
Purposes for 
PROM may 
differ amongst 
diagnostic 
groups; 
monitoring is 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
registered to 
National Health 
Service 
Return rate 67% 
monitored by 
respondents 
joint (1-20); on 
both UE and LE; 
single joint 
movements 
essential 
component of 
therapy but 
monitoring 
guidelines not 
specified; longer 
duration and 
increased 
frequency 
needed to 
prevent changes 
in muscle 
architecture 
Thelandersson, 
Cider, 
Volkmann, 2010 
To determine if 
PROM had an 
impact on 
intracranial, 
cerebrovascular, 
and 
hemodynamic 
parameters 
12 brain injured 
participants in 
neuro ICU; MV; 
IV or 
parenchymal 
catheter; arterial 
catheter in place; 
inability to move 
limbs actively 
Fracture or other 
problem 
preventing 
PROM 
Measures every 
minute for 10 
min before, 
during PROM 
and at rest for 10 
min 
PROM by PT in 
defined position; 
7 times in same 
order to UE/LE 
ICP, BP, MAP, 
HR, O2 
saturation 
TCD; ICP; BP; 
MAP; HR; 
pulsatility index  
In treatment 
group: No 
significant 
difference at any 
time point 
between HR, BP, 
and CPP 
measures except 
for PI increased 
(p<.01); ICP was 
significantly 
lower after 
exercise (p<.01) 
In control group: 
MAP, and 
systolic BP 
showed 
significant 
decreases after 
Used age and 
gender matched 
healthy control 
group 
Concluded 
PROM was safe 
 24 
Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
PROM (p<.01); 
no between 
group 
hemodynamic or 
cerebrovascular  
differences; no 
within group 
differences in 
cerebrovascular 
parameters 
Wiles & Stiller, 
2009 
To investigate 
PROM practices 
among 
Australian PTs 
51; PTs working 
in Level 3 ICUs 
in Australia 
NA NA 42-item 
questionnaire; 
closed end or 
semantic rating 
NA NA 86.3% had 
standing PT 
orders;13.7% 
required referral; 
only 13.7% 
performed  daily 
passive ROM; 
most common 
technique used 
was manual, but 
other techniques 
were used and 
varied widely; 
aims of 
treatment 
influenced 
choice of method 
PTs taught 
family to 
perform ROM or 
nurses performed 
it; PTs believed 
nurses did not 
perform PROM 
without 
direction; 
medical data 
dictated  
decision about 
treatment 
Winkelman, 
Higgins, & 
Chen, 2005 
To describe 
typical 
therapeutic 
activity in MV 
critically ill 
20; physiologic 
stability; MV in 
critical care 
setting 
Quadriplegia and 
stroke; recent 
surgery 
5-15 days after 
intubation (mean 
day 10) 
Observational 
study, 8 hours 
NA Motor 
Assessment and 
Activity Scale 
Actigraphy 
measured 
Most common 
activities were 
turning an 
PROM; 73% of 
therapeutic 
Placement of 
actigraphy 
device critical; 
actigraphy 
device records 
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Authors Purpose Inclusion, 
Sample Size 
Exclusion Timing Intervention Safety 
Measures 
Outcome 
Measures 
Statistically 
Significant 
Outcomes 
Comments 
patients; to 
compare two 
activity measures 
activity activities 
initiated by 
nurse; 11 
minutes of 
activity 
experienced 
during turning 
and 8 minutes 
for PROM per 8  
activity was 
infrequent and of 
short duration  
more than 
observed; 
precision a 
concern; no 
measure of 
activity intensity 
Winkelman, 
2010 
Exploration of 
types and 
duration of 
activity; 
feasibility of 
analyzing serum 
(test the 
procedure in 
advance of a 
larger study) 
17; Medical ICU 
or stepdown; 
COPD 
exacerbation; 
paO2/FiO2 100-
400;  FiO2<.6  
(see inclusion 
criteria) 
First observation 
48-60 hrs after 
unit admission; 
standardized 
time between 
10a and 2p; 2 
days of 
observation 
60 minutes of 
rest prior to 
activity, 20 
minutes planned 
activity, 10 
minutes data 
collection; 
activity provided 
by nurse; serum 
collection 
immediately 
following rest 
and then activity 
Vital signs, 
O2 saturation 
Activity duration 
(actigraph) 
Mean duration of 
activity 18.8 
minutes day 1, 
20 minutes day 
2; activity counts 
indicated low 
levels of activity; 
no difference 
between 
cytokine levels 
at rest or after 
activity; IL-6 
decreased on day 
2, IL-10 
increased on day 
2; O2 saturation 
was within 2% 
of baseline, HR, 
BP, RR within 
20% of baseline 
Large sample 
size necessary to 
determine impact 
of low level 
activity on 
inflammation 
(data used to 
calculate sample 
size for future 
studies)  
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Legend: APN=age predicted norm; ARDS=acute respiratory distress syndrome; AROM=active range of motion; BMI=body mass index; CAM-ICU=Confusion Assessment Method-Intensive Care Unit; 
COPD=chronic obstructive pulmonary disease; CRRT=continuous renal replacement therapy; CVP=central venous pressure; DBP=diastolic blood pressure; DNR=do not resuscitate; F=female; FiO2=fraction of 
inspired oxygen; GI=gastrointestinal; HR=heart rate; hrs=hours; ICP=intracranial pressure; ICU=intensive care unit; IV=intravenous; LE=lower extremity; LOS=length of stay; M=male; MAP=mean arterial 
pressure; MV=mechanical ventilation; NA=not applicable; NM=neuromuscular; NMB=neuromuscular blockade; OOB=out of bed; OT=occupational therapy; O2=oxygen; PAC=pulmonary artery catheter; 
paO2=partial arterial oxygen pressure; paCO2=partial arterial carbon dioxide pressure; PEEP=positive end expiratory pressure; PI=pulsatility index; PM=predicted maximum; PROM=passive range of motion; 
PT=physical therapy; RR=respiratory rate; SBP=systolic blood pressure; SOC=standard of care; TCD=transcranial Doppler; UE=upper extremity; UK=United Kingdom; 6MWD=six minute walk distance 
 
 
 
 
 27 
Findings 
What Constitutes Mobilization? 
Mobilization was found to cover a wide range of practitioner-delivered progressive 
activities, from passive and active range of motion (ROM), to dangling, standing or lift transfer 
to a chair, and ambulation.
13-15
 Range of motion was the most commonly applied mobilization 
intervention,
16-17
 but actual ROM practices were found to vary widely in duration and intensity 
amongst studies. Schweickert, et al.
13
 utilized 10 repetitions per joint in their study, while 
Thelandersson, Cider, and Volkmann
18
 used 7 repetitions per joint, and Morris, et al.
19
 used 5 
repetitions per joint. No rationales were provided for these choices. Wiles and Stiller
20
 identified 
2-30 (mean=13)  repetitions per joint  in their survey of Australian physical therapist practices in 
intensive care units, while Stockley, Hughes, Morrison, and Rooney
21
 reported 1-20 (mean 5) 
repetitions per joint in their study of physical therapist practices in the United Kingdom. 
Intensity, which constitutes partial to full stretch, was reported by therapists to also vary widely 
in both studies. All five studies reported provision of ROM to both upper and lower limbs.  
In an attempt to provide ROM in a more standardized manner and meet prescriptive 
guidelines (frequency, duration and intensity of therapy), mechanical devices have been used to 
provide upper and lower extremity passive and active exercise. Devices used include continuous 
passive motion machines and cycle ergometers. Griffiths, et al.
22
 found that three hours of 
passive movement daily in one leg of 5 critically ill patients increased muscle fiber and weight in 
the treated leg as compared to the untreated leg. Richard, Staley and Miller
23
 used a continuous 
passive motion machine in the upper and lower extremities of critically ill burn patients, while 
Burtin, et al.
24
 used a cycle ergometer for passive leg exercise in two 10 minute bouts, 20 
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cycles/minute in mechanically ventilated critically ill patients.  This device also allowed 
participants to progress to active cycling as their condition improved. Additional devices found 
in the literature included use of a tilt table for weight bearing
25
 and electrical stimulation of 
muscle contraction.
11, 26, 27
  
More active and aggressive approaches to mobilization have been recently advocated, 
particularly in mechanically ventilated critically ill adults,
13, 28 
and protocols have been used to 
specify step-wise succession of activity. Morris, et al.
19
 described a mobilization protocol that 
consisted of a four-step approach which began with passive range of motion (PROM), then 
progressed to active range of motion, then sitting, and then transfer. Another began with sitting 
and progressed to ambulation.
10
 Pohlman, et al.
12
 presented an algorithm to guide progression 
from passive ROM to ambulation, while Schweickert, et al.
13
 present a protocol that ranged from 
active ROM to ambulation. Protocols were noted to vary in their start and end points, but central 
activities (active range of motion, sitting, and transfer out of bed) were consistent. More recently, 
Hanekom, et al.
29
 described development of a clinical mobilization algorithm developed by a 3-
round Delphi process. However, the algorithm for unresponsive patients addressed only position 
changes while in bed, head of bed elevation, and daily passive range of motion as appropriate 
interventions, which may be insufficient for this population. While the consensus was significant 
(94%), less than 50% of statements were rated as essential, indicating provider disagreement 
about optimum approaches to mobilization. Further, Delphi participants were therapists and did 
not include other bedside practitioners such as nurses. 
Many participants in each of these studies were unable to progress to the protocol end 
point. Morris, et al.
19
 found that participants remained in the passive ROM stage of therapy for 
7.1 days before progressing to more active exercise, and 44(26.7%) of participants in a 
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progressive mobility study were not able to progress further than passive ROM. Reasons were 
decreased responsiveness and physiologic instability. Pohlman, et al.
12
 incorporated a 
mobilization protocol that began with active therapy, and found that even when participants 
(N=49) were able to perform active range of motion upon study entry, 13% were unable to 
participate in ongoing therapy sessions because of physiologic instability, and were reduced to 
passive activity only. Bailey, et al.
10
 initiated activity only after sedatives and catecholamines 
were discontinued, and when patients were deemed to be physiologically stable. Ambulation still 
comprised only 42% of all activity events. 
Who Should be Mobilized? 
Study samples in this review varied widely (Table 2) but participants commonly had 
respiratory failure and were mechanically ventilated, in addition to other comorbidities. 
Recognizing the severity of critical illness as a significant factor in potential muscle weakness, 
inclusion criteria often addressed the anticipated need for mechanical ventilation for at least 48 
hours.
10,12,13,19, 30
 Stable respiratory status was also identified as an inclusion criteria, described as 
FiO2 < .6 and PEEP < 10 cm H2O.  Heart rate, blood pressure and oxygen saturation within unit-
specified norms were common inclusion criteria. Although physical therapists usually consider 
cardiac reserve as an indicator for activity tolerance, little mention was made of those measures 
as being useful in guiding who to mobilize. Several studies included patients on vasoactive 
infusions or neuromuscular blockade,
15,22
 while others excluded such participants.
12,13
 The wide 
variation in mobilization study inclusion criteria suggests that clinician assessment is a critical 
component in deciding which patients should be mobilized. Lack of clearly defined evidence-
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based protocols or algorithms leaves clinicians with broad leeway in who receives 
mobilization interventions. 
The population of patients excluded from these studies warrants additional discussion. In 
the study by Stiller, Phillips and Lambert,
15
 participants comprised only 19% of the total ICU 
population during the study. Exclusions were made on the basis of level of consciousness and 
cardiovascular or respiratory instability. Schweickert, et al.
13
 excluded those with frequent 
desaturation, hypotension, new cardiac enzyme changes, new antidysrhythmic therapy, or recent 
ventilation mode change until those problems resolved. Additional exclusion criteria were: 
immunocompromise, cancer therapy, body mass index (BMI) > 45, greater than 72 hours of 
admission before intubation, non-ambulatory prior to admission, or do not resuscitate 
(DNR) status. The number of those excluded was not provided. Morris, et al.19 excluded those 
with increased intracranial pressure, neuromuscular disease, cardiac arrest, absent limbs or an 
irreversible disorder, and Bailey, et al.
10
 excluded any unresponsive patient. While the rationale 
for exclusion of some of these participants is logical, there is no empirical evidence to 
support many of the reasons for avoiding mobilization. Those excluded represent a 
substantial portion of the critically ill population, perhaps signaling important opportunities to 
improve outcomes. 
When Should Mobilization be Started? 
Optimum timing to initiate mobilization and duration of mobilization interventions is not 
clear in the literature, and patient condition alone does not appear to be the determining factor. A 
significant concern is that practitioners may perceive that mobilization is too difficult given the 
equipment or patient inability to participate, or it may be inappropriate due to concerns about 
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mobilization worsening physiologic instability.
11
 Loss of muscle mass and strength is evident 
soon after critical illness onset; 2% of mass may be lost within the first 24 hours of critical illness 
and this loss can progress exponentially.
31
 Since muscle changes appear soon after onset of 
critical illness,
32
 it is logical to consider implementation of mobilization soon after illness onset. 
Yet, mobilization is often delayed until physical stability is evident, often after an acute phase of 
illness,
33
 and delay may add to disability.
7
  
Early mobilization is a term that has recently appeared in literature, denoting 
mobilization activities begun in the critical phase of illness. Several investigators have 
demonstrated that it is feasible to implement mobilization soon after critical illness onset. 
Pohlman, et al.
12
 were able to institute mobilization in a mean 1.5 days after intubation, while 
Winkelman
14
 enrolled patients within 48 hours of intubation, and Schweickert, et al.
13
 enrolled 
participants within 72 hours of intubation. Although Burtin, et al.
24
 identified their study as 
“early,” participants were not considered for study entry before day 5 after intubation. However, 
even at 5 days, patients were mobilized sooner than the standard of care. Criteria to document 
readiness to institute mobilization have not yet been developed and require further exploration. 
Tolerance of passive exercise may be one signal that progression is appropriate. 
As a therapy, mobilization requires evidence-based descriptions of duration, intensity, 
and frequency, but limited evidence was found regarding these parameters in the literature. 
Using direct observation and actigraphic measurement of activity, Winkelman, Higgins and 
Chen
17
 documented 11 minutes of activity over an 8 hour period. In a subsequent study of 17 
mechanically ventilated patients with COPD, Winkelman
14
 was able to sustain progressive 
mobilization activities for 20 minutes, while Pohlman, et al.
12
 found the mean duration of active 
therapy at 26 + 14 minutes in their study of active exercise interventions. Burtin et al.
24
 were able 
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to add an additional 20 minutes of passive activity to their current mobilization protocol. 
Intensity is implied through progression, and has consistently been left up to the discretion of the 
practitioner, with clinical recognition of tolerance used as the progression decision point (but not 
specified). Daily frequency of therapy was the norm in studies,
10,12,13,14,20
 except for one study 
that reported passive ROM three times a day.
19
 Although no rationale for the daily therapy was 
found, the daily routine was most likely reflective of physical therapy rather than nursing 
practices.  
As a goal-directed therapy, the primary purpose of mobilization is to improve patient 
outcomes. This implies the need to continue mobilization interventions until measureable end 
points. Both short and long term outcomes have been reported in the literature. In a study of 330 
intubated patients in seven intensive care units (ICUs) in one hospital in North Carolina, Morris 
et al.
19
 demonstrated improved outcomes in participants who received a mobilization protocol 
(N=165) as compared to those who received standard of care (SOC; N=165).  A mobility team, 
consisting of a critical care nurse, nursing assistant (NA) and physical therapist (PT), delivered 
the mobilization protocol to participants who met criteria. The mobility protocol was started as 
soon as possible after admission, and continued daily throughout the ICU stay. Those receiving 
SOC received physical therapy per physician order or passive range of motion per nursing unit 
protocol (specified as “prn”). The team was assigned to one of the seven units on a monthly 
rotating basis, and geographic location of the patient determined whether they received SOC or 
the intervention. Although ventilator days did not differ among the two groups, the mobilization 
protocol group was out of bed sooner (5 vs 11.3 days, p<.001), had a shorter length of ICU stay 
(5.5 days vs 6.9 days, p=.02), and shorter length of hospital stay (11.2 vs 14.5 days, p=.006).  
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Similarly, Schweickert, et al.
13
 studied 104 critically ill mechanically ventilated patients 
from two academic medical centers that underwent daily interruption of sedation and 
mobilization. Using a computer-generated randomization scheme, participants were randomized 
to either SOC or a mobilization intervention; both groups received daily sedation interruption. 
The standard of care group (N=55) received physical therapy only as ordered by the physician. 
The intervention group (N=49) received daily passive range of motion, 10 times to each joint by 
a physical or occupational therapist. If the patient was able to interact, active-assisted and active 
range of motion (AROM) were added. If AROM was tolerated, then physical therapists began 
activities that progressed from sitting, to transfer, exercise in preparation for walking, and 
walking. The intervention group received significantly more therapy than the control group 
(p<.0001), and received therapy earlier (1.5 days vs 7.4 days, p<.0001). Only three patients in 
the SOC group progressed to ambulation while 12 patients in the intervention group progressed 
to ambulation. Although no significant differences were found in ICU or hospital lengths of stay 
between groups, the intervention group had higher functional status scores (p=.02), higher 
Barthel Index scores (p=.05), a higher number of independent ADLs (p=.06), and greater 
walking distance (p=.004) at hospital discharge than the SOC group. These findings are 
important in spite of the failure to impact length of stay data, as they may translate into lower 
costs for after hospital care and improved quality of life. After 5 days of intubation, Burtin, et 
al.
24
 instituted a passive cycling protocol in addition to ROM and progressive mobility. In spite 
of the delay in mobilization, patients who received passive cycling had significantly better 
exercise tolerance (p < .05), increased muscle force (p< .01), and improved perception of 
functional capacity (p < .05) upon discharge as compared to those who did not receive cycling 
therapy. Exercise-induced decreases in inflammation were postulated as one reason for the 
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treatment group outcomes. Whether a decrease in inflammation could be directly attributed 
to activity and improved outcomes is not yet known, but preliminary evidence suggests 
that cytokine profiles in critically ill patients may be improved by 20 minutes of sustained 
daily activity.14 
In spite of mounting evidence that mobilization improves outcomes, providers remain 
reluctant to order mobilization, citing safety concerns. Finding no empiric support for safety of 
mobilization in the critical care setting, Stiller, Phillips, and Lambert
15
 attempted to demonstrate 
that progressive mobilization was safe in critically ill patients in Australia. Thirty-one patients 
that were prescribed mobilization therapy as part of their care were included; they were enrolled 
in the study over three separate two week time periods to maximize population diversity, and 
most (78%) were mechanically ventilated. The 31 participants underwent 69 mobilization events 
during the study. Mobilization consisted of progressive activities that moved from lying to 
sitting, transfer and walking; only one patient progressed to walking. Safety measures assessed 
were those readily available at the bedside, and included heart rate (HR), systolic and diastolic 
blood pressure (BP), and oxygen saturation (SpO2). Oxygenation and respiratory reserve were 
calculated from available physiologic data. Safety measures were assessed immediately prior to 
mobilization, upon completion of the therapy, and after one minute of rest. Prior to mobilization, 
91.3% of participants had evidence of limited (but not severely compromised) cardiac or 
respiratory reserve. Both HR (p<.001) and BP (p<.001) were significantly increased during 
mobilization as compared to the baseline, but these increases were not deemed to be 
clinically significant nor did the changes require the intervention to be stopped. Of the 69 
mobilization events, three events were associated with desaturation and required intervention; 
baseline SpO2 was considered the limiting factor but the sample size was too small to allow 
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prediction. The authors concluded that mobilization was safe, even in the face of limited cardiac 
and respiratory reserve. It is important to note that mobilization was started in this study at a 
mean of 29 + 19.6 days after admission indicating that the mobilization therapies were 
implemented during a less critical phase of illness, perhaps at a time where participants had 
already developed substantial deconditioning and muscle weakness.  Morris, et al.
19
 enrolled 
study participants and began mobilization within 48 hours of intensive care admission; 44 
(26.7%) of the intervention participants did not progress beyond the first mobility level (PROM) 
but tolerated the intervention without incident. Sessions were withheld in only 1.4% of 
participants due to blood pressure (BP) concerns and in 0.9% due to heart rate (HR) concerns. 
Fatigue rather than vital sign change was cited as the most frequent reason for ending a therapy 
session, and these findings led the authors to conclude that early mobilization was safe. 
Schweickert, et al.
13
 began mobilization on study participants within 72 hours of intubation, and 
used standard unit blood pressure (<65 MAP or >110 MAP, or BP > 220 systolic), heart rate 
(<40 and >130), and oxygen saturation (<88%) parameters for provider notification as the 
guidelines for holding or stopping mobilization. Mobilization was stopped in 4% of participants 
in response to ventilator dyssynchrony, and only one episode of desaturation was noted, 
supporting the safety of mobilization within 72 hours of intubation. When mobilizing patients to 
the chair and ambulation after 5 days of intubation, Bailey, et al.
10
 encountered only 14 adverse 
events in 1440 episodes of activity (1%). None of the adverse events added additional length of 
stay or cost. Commonly measured physiologic criteria served as safety measures and varied 
across studies, as did parameters for stopping or hold mobilization activities. All authors mention 
the need for ongoing safety assessments for any mobilization intervention. Limited information 
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was available on physiologic effects of passive activity alone, especially in patients with 
cardiopulmonary compromise. 
Concern has been expressed about early mobilization contributing to increased muscle 
inflammation, which may actually compound rather than prevent muscle weakness.
6
 An increase 
in inflammation in response to exercise may be measured via cytokine levels, specifically IL-6 
and IL-10. Stability in cytokine levels would serve as a safety indicator for mobilization, while 
decline in pro-inflammatory cytokine levels or improvement in pro- to anti-inflammatory ratios 
would serve as an efficacy measure. Winkelman, Higgins and Chen
17
 demonstrated no 
significant changes in cytokine levels with passive activity (< 15 min), suggesting that passive 
activity does not increase inflammation. However, further study would add to safety support for 
this intervention.  
Physiologic instability in mechanically ventilated critically ill patients may persist for 
days to weeks, delaying use of mobilization interventions. The loss of muscle soon after critical 
illness onset suggests that muscle protective interventions should be started early in the course of 
critical illness, probably within the first twenty-four hours. Passive exercise may be the most 
appropriate activity for these patients in the early phase of illness.
8
 However, empirical evidence 
supporting the safety or efficacy of passive activity was not found, particularly during periods of 
physiologic instability. Further, prescriptive parameters for passive activity have not been 
identified for this population. 
Who Should Deliver Mobilization? 
Several different practitioners, including nurses, nursing assistants, occupational 
therapists and physical therapists delivered mobilization interventions in the studies 
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reviewed.
10,12,15,19,34
 While physical therapists and nurses were integral to all protocols, the 
protocols tended to be therapist-driven. Garzon-Serrano, et al.
35
 reported that physical therapists 
mobilized patients at a higher level than nurses, and nurses more commonly used passive activity 
while therapists performed more active interventions. In addition, barriers perceived by nurses 
and therapists differed; nurses perceived hemodynamic instability and renal replacement therapy 
(RRT) as the two most significant barriers while therapists perceived neurologic impairment as 
the most significant barrier. Interestingly, no study has addressed whether hemodynamic 
instability or presence of RRT are true barriers to mobilization, as these factors have been used 
as exclusion criteria. Limited evidence exists that mobilization is appropriate for neurologically 
impaired patients.
18 
Although underemphasized, a team approach to mobilization was noted to be universal 
across studies. This could be due to the collaborative multidisciplinary approach that is more 
common in critical care, or the complexity of clinical decision-making required in this setting. 
Additionally, mobilizing a patient that may be unable to assist or that has a multitude of tubes, 
lines, and drains requires many hands. Garzon-Serrano, et al.
35
 suggested that capitalizing on 
different team member contributions could enhance overall mobilization in the critical care 
setting. While mobilization is clearly within the scope of nursing practice, nursing involvement 
in study protocols and reports was limited. Only six of the15 studies included nurses as authors; 
three of those were primary authors. Nursing involvement was constrained to assessment, 
implementation of passive activity only, or assistance with mobilization under the direction 
of physical therapists. 
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Discussion and Implications  
Knowledge that supports decisions about how and when to mobilize critically ill patients 
is evolving. Nurses and other bedside practitioners have a “toolbox” of mobilization activities 
that can be used to progressively mobilize their patients, but the evidence supporting specific 
mobilization approaches is limited. Treatment routine and starting and ending points varied 
across studies, and even standard of care differed when randomization was used. With treatment 
routines varying so widely, comparing study outcomes is challenging at best. Clinical trials that 
incorporate progressive mobilization across broad populations of critically ill patients are 
needed, along with studies that demonstrate benefit of creative approaches to mobilization at the 
bedside. 
Differing perceptions of what constituted adequate mobilization may have accounted for 
protocol variations. Little attention was given to passive activity in the studies reviewed. This 
may be due to the fact that passive therapies are not billable services for physical therapists, and 
passive activity is often relegated to the realm of nursing care. However, it may be that passive 
activity is the most appropriate initial mobilization activity for most critically ill patients. Passive 
exercise can be delivered early in critical illness, but further study is needed to clarify the 
optimum method, duration, and frequency.  Criteria for patients who should be mobilized must 
be broadened beyond the strict inclusion criteria for studies in this review, as many critically ill 
patients may be unnecessarily denied this important intervention. Empirical evidence for those 
who should not be mobilized requires further development as well.  
Nurses and physical therapists differ in their approaches to mobilization. It is evident that 
a team approach is required to implement mobilization protocols, and nurses are key members. 
Nurse-driven protocols for early mobilization require further development, and team roles 
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require further delineation. While nurses have many competing agendas that may limit ability to 
implement mobilization activities, mobilization should not be solely within the realm of physical 
therapy. Nurses must view mobilization from the perspective of a prescriptive therapy, and 
address greater intensity, longer duration, and greater frequency concerns, especially with 
passive activity.  
Addressing practitioner perceived barriers to mobilization is necessary, particularly if the 
perceived barriers are not supported by evidence. Perceived barriers represent opportunities for 
education as well as research. Approaching mobilization as an interdisciplinary process may also 
limit perceived barriers.
36
 Sedation is one important barrier to mobilization that has received 
little attention in the studies reviewed. Limiting amount and duration of sedation, or providing a 
“sedation vacation” may significantly impact the mobilization provided as well as improve 
outcomes.
35 
Development of evidence-based clinical decision tools that can be implemented across 
settings may facilitate implementation of mobilization protocols for critically ill patients. It is 
beyond time to question whether mobilization is of benefit, but rather time to move toward 
evidence that supports optimum approaches. 
The rationale for why mobilization may be effective in improving outcomes from critical 
illness deserves further attention. The current logic is that mobilization may diminish 
inflammatory effects on muscle, but limited evidence exists supporting this logic. Inflammatory 
markers may provide explanation for benefit of mobilization as well as indicators for those who 
should not be mobilized.
37
 Additional benefits of mobilization also requires further exploration. 
It could be that mobilization may decrease pain, anxiety, delirium, need for sedation, and even 
insulin requirements. Reduction of these factors may provide some degree of muscle protection. 
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Limitations to this review included the exclusion of non-English articles. Further, 
substantial practice changes have occurred from the time of the earliest article reviewed (1994). 
However, thirteen of the articles reviewed for this analysis appeared in literature from 2004 
forward.  
Summary 
Immobility and inflammation weaken muscle in critically ill patients. Mobilization is 
thought to produce physiologic effects that preserve muscle function. Several different and 
progressive approaches to mobilization, beginning with passive range of motion, may be used, 
with progression of activity based on patient tolerance. With muscle damage occurring early 
after critical illness onset, early mobilization is advocated, but safety concerns abound. Passive 
activity, if demonstrated to be safe, may provide early benefit to those critically ill patients who 
are not yet able to tolerate progressive activity. Gaps in the literature are related to inconsistent 
use of a mobilization techniques, lack of identification of optimum timing for initiation of 
mobilization, and lack of inclusion of a population in great need of muscle protection. Further, 
findings related to the inflammatory response to activity are contradictory, requiring further 
exploration.  
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CHAPTER 3: FINDINGS 
Abstract 
Muscle weakness is the most common and persistent problem after a critical illness. Early 
mobilization of the critically ill patient, beginning with passive exercise and progressing to 
ambulation, may mitigate muscle effects of the critical illness. However, mobilization may 
produce adverse effects, especially early in the illness when risk for physiologic deterioration is 
common. If safe, introducing a mobility intervention early in the illness may facilitate weaning, 
shorten intensive care unit and hospitals stays, and improve quality of life for mechanically 
ventilated critically ill patients.  
The aim of this study was to assess the cardiopulmonary, neurodynamic, pain and 
inflammatory responses to an early standardized passive exercise protocol (PEP) in mechanically 
ventilated critically ill patients. Using a quasi-experimental within-subjects repeated measures 
design, mechanically ventilated critically ill adults who were physiologically stable underwent a 
single standardized passive exercise intervention within 72 hours of intubation. The intervention 
consisted of 20 minutes of bilateral passive leg movement delivered by continuous passive 
motion machines at a rate of 20 repetitions per minute, from 5-75 degrees, to simulate very slow 
walking. Physiologic parameters evaluated included heart rate (HR), mean blood pressure 
(MBP), oxygen saturation, intracranial pressure (ICP) and cytokine levels, obtained before, 
during, and after the intervention. The Behavioral Pain Scale, administered before, during and 
after the intervention was used as a measure of participant comfort.  
The study sample was comprised of 18 (60%) males and 12 (40%) females, with a mean 
age of 56.5 years (SD 16.9 years), who were primarily Caucasian (N=18, 64%). Mean APACHE 
II scores for the sample were 23.8 (SD 6.2) with a mean predicted death rate of 48.8 (SD 19.8), 
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indicating moderate mortality risk related to illness severity. Number of comorbidities ranged 
from 1-10 (X=4). All participants completed the intervention with no adverse events. Using 
repeated measures analysis of variance (rmANOVA), no significant differences were found in 
heart rate, blood pressure, or oxygen saturation at any of the four time points in comparison to 
baseline. Behavioral Pain Scale scores were significantly reduced (p=.02) at 10 and 20 minutes 
after the PEP was started, and were sustained. IL-6 was significantly reduced (p=.03) at the end 
of the intervention but not at the final time period. IL-10 values were not significantly different 
at any of the three time points, but IL-6 to IL-10 ratios decreased significantly (p=.05) from Time 
0 to Time 3, and Time 3 to Time 4. 
Passive leg exercise was well tolerated. HR, MBP, and oxygen saturation were 
maintained within unit specified range during and for one hour after activity, and patient comfort 
improved during and after exercise. A downward trend in heart rate was noted in participants, 
which is contrary to usual heart rate response during exercise, but may actually represent clinical 
improvement in this population. Reduction of mean IL-6 values at Time 3 but not Time 4 
suggests that the PEP was responsible for the improvement.  Improvement of IL-6 to IL-10 ratios 
over both time periods suggests that IL-10 improvements may occur later than the time period of 
study. 
Passive exercise should be studied as an approach to facilitating mobilization in 
mechanically ventilated critically ill adults until they are ready to participate in more active 
exercise. It could be that more aggressive exercise, such as passive cycling at faster rates, will be 
tolerated in this population. Cytokines may be used to explain benefits of mobilization in this 
population.  
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Introduction and Background 
Muscle weakness commonly occurs after a critical illness, contributing to fatigue, poor 
functional status and decreased health-related quality of life long after the critical illness has 
resolved.
1,2
 Immobility and the inflammatory process diminish both muscle mass and strength, 
which can prolong need for mechanical ventilation, extend hospital stay, and complicate 
recovery, as well as negatively impact quality of life for the individual with critical illness.
3,4 
Progressive mobilization interventions, from passive and active range of motion (ROM), to 
dangling, standing or lift transfer to a chair, and ambulation,
5-7 
have been recommended as  one 
approach to minimizing muscle weakness after a critical illness.
8
 Mobilization is hypothesized to 
preserve muscle strength and mass by improving blood flow, stimulating anti-inflammatory 
cytokine production and enhancing insulin activity and glucose uptake in muscle.
4 
 
Mobilization has been shown to improve outcomes for critically ill adults. Positive 
outcomes related to mobilization include significantly shorter lengths of intensive care unit 
(ICU) and hospital stays and improved functional outcomes.
5,7
 In one study where ventilator time 
and length of stay were not significantly decreased after employing an exercise protocol, 
significantly lower costs for after-hospital care and improved quality of life were noted.
9
 
Several issues complicate the delivery of mobilization interventions, including timing of 
the interventions, widely variable practices, and the possibility that mobilization and related 
factors such as pain can aggravate the inflammatory process. Optimal timing for initiating 
mobilization is not known. Several studies have begun mobilization 5 days or longer after illness 
onset,
6,10
 but with muscle loss beginning within the first twenty-four hours of critical illness, this 
time frame misses an important window of opportunity to improve outcomes. Early mobilization 
(within the first 24-48 hours of critical illness) has been advocated,
11,12
 and the feasibility of 
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early mobilization, within 24 hours of intubation, has recently been demonstrated.
5,13
 However, 
physiologic instability commonly occurs early in critical illness, and providers may be reluctant 
to mobilize a patient who is physiologically unstable. Activity intolerance, manifested as 
unstable vital signs, is often a limiting factor in application of mobilization activities,
5,8
 and 
many patients have been unable to participate in progressive therapy sessions because of 
physiologic instability.
13 
Physiologic instability in mechanically ventilated critically ill patients 
may persist for days to weeks, delaying active mobility interventions, which may add to 
disability.
9,14
 It may be that passive exercise is the most appropriate activity for critically ill 
patients in the early phase of illness,
8 
and it can be employed until a patient is ready to progress 
to more active interventions.
 
However, limited empirical evidence exists to support the safety or 
efficacy of passive activity, particularly during periods of physiologic instability. Further, criteria 
to document readiness to institute or progress mobilization have not yet been developed. 
Tolerance of passive activity may be one signal that institution and progression are appropriate.  
Another concern is that mobilization practices vary widely. Practices for active 
mobilization include active or resistive range of motion, chair sitting, dangling, standing, 
ambulating, and use of a tilt table.
5-7
 Passive activities also vary. Passive activity can be 
delivered manually by therapists or nurses, or via machines such as cycle ergometers or 
continuous passive motion machines. Studies have reported manual passive exercise repetitions 
of 5, 7, and 10 per joint, but no rationales were provided for these choices.
5,15,16
 In two separate 
surveys of physical therapist practices, 2-30 (mean=13) repetitions per joint and 1-20 (mean 5) 
repetitions per joint per day in were reported.
 17,18
 Several studies used a specified time rather 
than repetitions per joint for ROM. Time periods ranged from 20 minutes
19
 to 26 + 14 minutes.
13
  
Burtin et al. added 20 minutes of passive activity via a passive cycling machine to a mobilization 
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protocol.
10
 With treatment routines varying widely, it is difficult to compare patient outcomes. 
Standardized mobilization routines that consider therapeutic parameters of duration, intensity 
and frequency, and that may be readily replicated and applied in critically ill patients are critical 
to demonstrating improved outcomes from mobilization. Mechanical devices, such as continuous 
passive motion machines and passive cycling devices, have been suggested as an approach to 
standardize therapy at a duration and intensity that can meet prescriptive guidelines.
10,15
 
Further concern has been expressed that early mobilization contributes to increased 
muscle inflammation, which may compound rather than prevent muscle weakness.
20
 
Inflammatory markers did not significantly change with passive activity less than 15 minutes 
duration, suggesting that passive activity does not increase inflammation.
21
 Whether a decrease 
in inflammation could be attributed to activity and improved outcomes is not yet known, but 
preliminary evidence suggests that 20 minutes of sustained activity daily could improve cytokine 
profiles in critically ill patients.
19
 Further study would add to safety support for this measure as 
well as possibly provide a physiologic explanation for benefit of mobilization.  
The effect of mobilization on pain in critically ill patients has not been studied, and it is not 
known whether mobilization causes or reduces pain.
22,23
 Pain increases cortisol secretion and 
production of pro-inflammatory cytokines, which may be deleterious to muscle.
24
 Administration 
of morphine for pain management decreases inflammatory cytokines, suggesting that managing 
pain may be muscle protective.
25
 Studying the pain response to mobilization may add additional 
support to benefits of mobilization or dictate precautions during implementation. 
Passive activity, if demonstrated to be safe, may provide early benefit to those critically 
ill patients who are not yet able to tolerate progressive activity. This study sought to identify 
physiologic, pain and inflammatory responses to a standardized passive exercise intervention 
 50 
instituted early in critical illness. Introducing a passive exercise intervention early in critical 
illness may be muscle protective, which could facilitate weaning, shorten intensive care unit and 
hospitals stays, and improve quality of life for mechanically ventilated critically ill patients.  
Methods 
Design and Consent 
This study used a quasi-experimental within-subjects repeated measures design, with 
subjects serving as their own controls. Study participants were enrolled within 48 hours of 
intubation, and received a single 20 minute standardized passive exercise intervention within 72 
hours of intubation. This time frame was designed to test the intervention on participants early 
after intubation, and allowed the intervention to be delivered within a consistent time frame. 
Institutional review boards at the clinical agency and university approved the study. 
Informed consent was obtained from the proxy for the critically ill patients who met eligibility 
criteria. If the patient was responsive at the time of consent, they would have been approached 
for consent, but all eligible patients were either sedated or unresponsive. 
Setting and Sample 
The study was conducted in a tertiary care setting in southeastern United States. Subjects 
were recruited from three critical care units: burn-trauma, neuroscience and multisystem. Care in 
these settings was directed by either medical or surgical intensivists. The intensivists provided 
assent for participant involvement in the study. The electronic medical record was screened daily 
in each unit for potential participants. 
 A convenience sample of 32 critically ill adults was enrolled in the study between 
October 2011 and February 2012. Figure 2 demonstrates the screening to enrollment flow chart.  
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Figure 2. Screening to enrollment flow chart. 
 
Inclusion criteria were: age 18 years or older; intubation and mechanical ventilation 
initiated within 48 hours of enrollment and anticipated for at least 72 hours; ambulatory prior to 
admission, presence of a vascular access device for blood sampling; and vital signs within unit-
specified norms (Table 3).  
 
Table 3. Order Set Specified Normal Ranges of Vital Signs. 
Variable Normal Range 
Heart rate Heart rate > 50/min but < 130/min 
Blood pressure  Mean arterial blood pressure > 60 mmHg but < 130 mmHg 
Oxygen saturation >88% (to accommodate for potentially low hemoglobin levels, 
oxygen saturation >90% was used for this study) 
Intracranial pressure Intracranial pressure < 20 mmHg 
 
 
 
240 screened 
155 met exclusion criteria 
4 Physiologically unstable 
19 Planned withdrawal 
16 Unable to locate proxy 
14 Declined 
32 Consented 
30 Proceeded to intervention 
2 deteriorated 
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Persons who were hospitalized or non-ambulatory prior to critical illness onset, or with 
evidence of active cardiac ischemia, absent or injured limbs, inadequate lower extremity range of 
motion, or spinal, pelvic or lower extremity instability were excluded. Two hundred forty 
patients were screened and 155 initially met exclusion criteria. Spinal, pelvic or lower extremity 
instability was the most common exclusion criteria, followed by evidence of cardiac ischemia. 
Patients that were physiologically unstable or had no known proxy were screened daily until 
stability was attained, a proxy was located, or the time frame was extended beyond the 
intervention window. This resulted in exclusion of an additional 20 patients. Planned withdrawal 
of life support provided an additional 19 exclusions, and 14 families declined study involvement.  
The intervention was not tested on two participants that were consented: one due to surgery and 
the other due to unplanned extubation. 
Using G-Power a-priori to calculate sample size, for a medium effect size of .25, a 
significance level of .05, power of .80, and the four time point comparisons to baseline, sample 
size was calculated at 24. With only three time points for the cytokine values, the calculated 
sample size rose to 28. Because the study variables were collected over a short period of time 
(about 2 hours), attrition rate was expected to be low once the intervention was begun. However, 
because attrition could occur from the time of consent to implementation of the intervention, 
allowing for a10% attrition rate, a total sample of 31 was anticipated. 
Measures 
Demographic and Cardiopulmonary Measures  
Demographic data were obtained from the electronic medical record. Existing bedside 
monitoring systems (Phillips Intellivue M70) were used to continuously measure heart rate, 
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arterial blood pressure, oxygen saturation and ICP. Measures of ICP were obtained when 
available but were not required for study enrollment. Standardized placement of monitoring 
devices was assured prior to starting the study and measures were taken to assure precision and 
accuracy of heart rate, blood pressure, oxygen saturation and ICP measures (Table 4).  
 
Table 4. Measures for Standardized Data Collection of Dependent Variables. 
Measure Measurement 
Technique 
Standardized Approach 
Heart rate 5-lead 
electrocardiogram 
Lead placement as follow: right arm- under right 
clavicle at right bursal junction; right leg- 
anterior midline between 7
th
 and 8
th
 right ribs; 
left arm- under left clavicle at left bursal 
junction; left leg- anterior midline between 7
th
 
and 8
th
 left ribs; V- between fourth and fifth 
intercostal spaces, and between left sternal 
border and midclavicular line; waveform visible 
on monitor 
Blood pressure Arterial catheter Transducer placed at phlebostatic axis; 
waveform visible with three-notch waveform on 
monitor corresponding to arterial pulsations; 
zeroed against atmospheric pressure. 
Oxygen saturation Pulse oximetry May be placed on finger, toe, earlobe; waveform 
visible with pulsatility on monitor corresponding 
to heart rate  
Intracranial 
pressure 
Ventricular catheter Transducer placed level with external auditory 
meatus; waveform visible with three-notch 
waveform on monitor corresponding to arterial 
pulsations; stopcock set to monitor only. 
 
 
All physiologic values were obtained using the Phillips Intellivue M70 monitoring 
systems which are standard at the bedside in the units of study. Sensitivity and specificity data 
for this monitoring system is within industry standards and may be found in the operational 
manual (both are >.9). Monitor alarms were set at the parameters indicated by critical care order 
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sets (Table 3). To assure that measures were synchronous with the intervention, the investigator 
used the time displayed on the bedside monitor which was timed to be congruent with data that 
downloaded into the electronic medical record. 
Pain Measure  
The Behavioral Pain Scale, used clinically at the bedside at the time of study, was used as 
a pain measure during the study period. It has demonstrated adequate internal reliability with 
Cronbach alphas ranging from .64-.72 and intra-class correlations of .95.
26, 27 
Significant changes 
in Behavioral Pain Scale scores have been noted during painful procedures in minimally 
responsive adults, supporting validity in this setting.
27
 Inter-rater reliability for the Behavioral 
Pain Scale between the investigator and nurse educator was .95.  All Behavioral Pain Scale 
measures were obtained by the investigator. 
Inflammatory Markers  
Interleukin (IL)-6 and IL-10 were used as markers for inflammation during the study 
period. The study intervention was completed between 0800 and 1400 to minimize diurnal 
effects on cytokine values. Plasma cytokine levels were obtained from either an intra-arterial 
catheter or venous access device. There is no known difference between cytokine values 
obtained by arterial or venous sampling; however, a direct stick may induce an inflammatory 
response and artificially elevate the cytokine levels.
28
 An established arterial or venous access 
device suitable for blood sampling was part of inclusion criteria. Blood samples were obtained, 
prepared and analyzed by the investigator according to a predetermined protocol to assure 
precision and accuracy (Appendix A). Following generation of a standard curve using known 
concentrations of each interleukin, IL-6 and IL-10 values were obtained using a commercially 
 55 
prepared human enzyme-linked immunosorbent assay (ELISA). Assays for IL-6 and IL-10 
samples were conducted in duplicate and all values were expressed as mean concentrations for 
each of the three time periods.  The IL-6 to IL-10 ratio was also calculated for each of the three 
time points. The ratio between the two values may be clinically important as IL-6 is a pro-
inflammatory cytokine while IL-10 is an anti-inflammatory cytokine that are usually maintained 
in approximately 2or 3:1 balance.
29 
Procedures 
Once informed consent was obtained, inclusion and exclusion criteria were re-reviewed 
and a decision about the participant’s ability to proceed to the intervention was affirmed. The 
study period began with a 30-minute rest period. Prior to start of the rest period, care activities, 
such as repositioning, suctioning, examination or hygiene measures, were performed by the 
direct care nurse in order to limit the influence of other activity on study outcomes. At the end of 
this rest period (T0), baseline measures were obtained: 1) cardiopulmonary measures of heart 
rate, mean blood pressure, and oxygen saturation; 2) ICP and the calculated cerebral perfusion 
pressure (CPP), if available, 3) a Behavioral Pain Scale score; and 4) a blood sample to assess 
cytokine levels. Legs were placed in the continuous passive motion (CPM) machines by the 
investigator, and the intervention was started.  
Heart rate, systolic, diastolic and mean arterial blood pressures, oxygen saturation, ICP (if 
available) and Behavioral Pain Scale score were assessed at 5 minutes (T1) and 10 minutes (T2) 
during the intervention, and upon completion of the intervention (at 20 minutes, T3). Legs were 
removed from the CPM machines, and 60-minute rest period began. At the end of the rest period 
(T4), heart rate, mean blood pressure, oxygen saturation, ICP (if available) and Behavioral Pain 
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Scale score were again assessed (T4). A blood sample for assessment of cytokine levels was 
obtained upon completion of the PEP (T3) and at the end of the rest period (T4).  
Any patient-initiated or provider-initiated activity during the study period was recorded 
by the investigator. Family members were allowed to be at the bedside during the intervention if 
requested and their presence was also recorded. The investigator was present in the room during 
the entire study period and all physiologic measures were directly downloaded into the medical 
record and recorded by the investigator.  
Intervention 
The passive exercise protocol (PEP) consisted of 20 minutes of 20 flexion-extension 
(from 70
o
 flexion to 5
o
 flexion) episodes per minute in each leg simultaneously. Leg movements 
were alternated so that one leg was flexed while the other was extended, simulating slow 
walking.  
The CPM machines, manufactured by Furniss Corporation are movement therapy devices 
that are approved for use in hospital, rehabilitation and home settings. Two CPM machines were 
used for each intervention to standardize the degree of knee and hip flexion. To assure precision 
in delivery, the same device was used on each right leg and each left leg for each participant. The 
device was placed on the flat surface of the bed below the leg; the leg was positioned in thigh, 
calf and foot supports. Supports were padded to prevent skin breakdown, and a stabilizing device 
at the knees prevented lateral rotation at the knee or hip. A handheld device was used to set the 
number of flexion-extension repetitions per minute (range 1-20) as well as degree of flexion 
(range 0
o
-95
o
). The CPM machine had a resistance alarm which halted movement as an 
additional safety measure. Precision and accuracy have been determined by the manufacturer; 
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electrical safety of the equipment was determined by the biomedical engineering department at 
the institution. The investigator completed a training program offered by the supplier and 
delivered the intervention. 
Study End Points 
The primary study endpoints were safety endpoints, and included maintenance of heart 
rate, mean blood pressure, oxygen saturation, and ICP within the range specified by critical care 
order sets (Table 3), during and for 60 minutes after the passive exercise protocol. The secondary 
endpoints were maintenance of observed pain level during and 60 minutes after the passive 
exercise protocol within one point of baseline, and cytokine levels upon completion and 60 
minutes after maintained within 5% of baseline values. 
Data Analysis 
Repeated measures analysis of variance (rmANOVA) was used to determine whether a 
significant change occurred in the heart rate, mean arterial blood pressure, oxygen saturation, 
ICP and Behavioral Pain Scale score from baseline (T0) at any of the four subsequent time points 
(T1-T4). Repeated measures analysis of variance was also used to determine whether a 
significant change occurred in IL-6 and IL-10 levels as well as the ratio between the two from 
baseline (T0) at any of the two subsequent time points (T3 and T4). The a-priori level of 
significance was set at 0.05 for these tests. As this was primarily a safety study, lack of 
significant change in variables was the anticipated outcome. Because changes in the variables 
may be statistically significant without being clinically significant, any statistically significant 
change in the dependent variables was compared to the clinical parameters previously defined. 
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Only statistical significance of change in cytokine levels was considered because clinical 
significance is currently unknown. 
Results 
Sample 
Demographic data and baseline characteristics for all participants are summarized in 
Table 5.  
 
Table 5. Baseline Sample Characteristics. 
Variable Descriptor 
Mean (SD) or Frequency (%) 
Age in years 56.5 (16.9); Range 21-90 years  
Race 
     Caucasian 
      African-American       
      Asian 
                  
19 (63.3%) 
7 (23.3%) 
4 (13.3%) 
Ethnicity 
     Hispanic 
     Non-Hispanic 
 
8 (26.7%) 
22 (73.3%) 
Gender 
     Male 
     Female 
 
18 (60%) 
12 (40%) 
APACHE II  
Predicted Death Rate Mean 
23.77 (6.2); Range 13-39 
48.8  (19.8); Range 16.5-89.8 
BMI 28.7 (SD 9.3) 
12 overweight 
  4 Grade I obesity 
  4 grade III obesity (morbidly obese) 
Primary Reason for Admission 
     Neurologic 
     Respiratory    
     Abdominal 
     Cardiac 
     Hematologic 
     Sepsis/Infection 
     Other 
                 
15 (50) 
  7 (23) 
  4 (13) 
  1 (3) 
  1 (3) 
  1 (3) 
  1 (3) 
Co-morbidities* 3.93 (1.9); Range 1-8 
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Variable Descriptor 
Mean (SD) or Frequency (%) 
     Respiratory 
     Cardiac   
     Endocrine   
     Hematologic 
     Other   
     Urinary   
     Sepsis/Infection   
     Abdominal       
     Neurological        
     Musculoskeletal   
 
33 
22 
21 
12 
10 
  8 
  6 
  4 
  1 
  1 
All participants had at least one co-morbid condition; 4 
had multiple co-morbidities within the same system 
Sedation* 
     Yes 
     No 
 
25 (83.3%) 
  5 (17.7%) 
Neuromuscular Blockade* 
     Yes 
     No 
   
  1 (3.3%) 
29 (96.7%) 
Beta-Blockers within 48 hours of 
study participation 
   Yes 
   No 
 
 
  5 (16.7%) 
25 (83.3%) 
Narcotics* 
     Yes 
     No 
 
23 (76.6%) 
  7 (23.3%)  
Glasgow Coma Scale Score* 7.8 (2.8); Range 3-13 
Hemoglobin, mg%* 10.2 (1.8); Range 7.0-14.5 
Glucose, mg/dl* Mean 149.8 (48.7); Range 84-322 
Ventilator Mode* 
     SIMV 
     Assist control 
 
16 (53.3%) 
14 (46.7%) 
Pressure Support cmH20* 
     Yes 
     No 
11.2 (2.3); Range 10-18 
17 (56.7%) 
13 (43.3%) 
Minute Volume, L/min* 8.5 (2.5); Range 5.5-16.4 
Fraction of inspired oxygen (FiO2)* 35.33% (7.5); Range 30%-60% 
Positive end-expiratory pressure, 
cmH2O* 
5.5 (1.5); Range 5-10 
All participants received PEEP 
Ventilator change during study 
period 
     Yes 
     No 
 
   
1 (3.3%) 
29 (96.7%) 
Activity during the rest period 1  
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Variable Descriptor 
Mean (SD) or Frequency (%) 
     Yes 
     No 
  8 (26.7%) 
22 (73.3%) 
Activity during the rest period 2 
     Yes 
     No 
 
17 (56.7%) 
13 (43.3%) 
Hours after intubation 38.0 (17.6); Range 4.8-67.5 
Hours after admission 38.9 (18.3); Range 4.0-67 
*at start of intervention 
 
The mean age for participants was 56.5 years (range 21-90 years, SD 17 years); they 
were predominantly white (63.3%), non-Hispanic (73.3%), and male (60%); and admitted for 
neurologic (50%), respiratory (23%), or gastrointestinal problems (13%). All participants had at 
least one co-morbid condition (X=3.93, SD 1.9). The majority of participants were sedated at the 
time of the intervention (83.3%) and the mean Glasgow Coma Scale score was 7.8 (SD 2.8). 
Drugs used for sedation included fentanyl (70%; mean dose 96.7mcg/hr), midazolam (30%; 
mean dose 3.67 mg/hr), and propofol (26.7%; mean dose 35 mcg/kg/min). Seven (23.3%) 
participants received a combination of fentanyl and midazolam; 7 (23.3%) received fentanyl and 
propofol; 5 (16.7%) received fentanyl alone; 4 (13.3%) received propofol alone; and 2 (7%) were 
on benzodiazepines for sedation. Participants were treated with synchronized intermittent 
mandatory ventilation (53.3%), pressure support (56.7%) at a mean of 11.2 cmH20 (SD 1.5), 
mean minute volume of 8.5 L/min (SD 2.5) , mean FiO2 of 35% (SD 7.5), and all received 
positive end expiratory pressure (mean 5.5 cmH2O, SD 1.53). Mean APACHE II score was 23.8 
(SD 6.2), with a mean predicted death rate of 48.8 (SD 19.8). The intervention was implemented 
a mean 38 hours (SD 17.56) after intubation (mean 38.9 hours after admission, SD 18.34). All 
participants were able to complete the intervention, and no adverse events were encountered. 
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Physiologic Responses to the PEP 
Mean systolic blood pressures ranged from 130.77-135.03 mmHg, diastolic blood 
pressures ranged from 65.13-66.10 mmHg, and mean arterial pressure ranged from 86.97-88.20 
mmHg across time points.  Heart rate means ranged from 91.03-96.20 beats/minute and oxygen 
saturation means ranged from 98.07%-98.40% across time points. Sample means were well 
within the normal ranges for physiologic variables at all study points (Table 6).   
 
Table 6. Means and Standard Deviations for Physiologic Variables and Behavioral Pain Scale. 
Time Systolic BP Diastolic BP Mean BP 
 Mean SD Mean SD Mean SD 
0 134.07 19.47 65.67 12.60 88.20 11.60 
1 131.37 17.36 66.10 13.27 87.43 10.99 
2 135.03 28.73 65.13 12.27 86.97 10.66 
3 133.70 19.84 65.23 12.51 87.70 11.93 
4 130.77 19.41 65.87 14.78 87.10 14.40 
 
Time Heart Rate Oxygen Saturation Behavioral Pain Scale 
Score 
 Mean SD Mean SD Mean SD 
0 96.20 18.78 98.07 2.49 3.77 1.04 
1 94.77 19.43 98.10 2.40 3.27 .58 
2 93.70 17.70 98.40 1.92 3.23 .63 
3 93.00 18.57 98.33 2.06 3.27 .83 
4 91.03 17.52 98.40 2.09 3.27 .64 
 
 
Systolic, diastolic and mean blood pressures and oxygen saturation did not change significantly 
from baseline at any of the time points (Table 7).  
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Table 7. One-way rmANOVA Analyses for Physiologic Variables. 
Variable df
a 
F
a 
p
a 
Systolic BP 2.04, 59.20 .81 .45 
Diastolic BP 1.98, 57.54 .14 .87 
Mean BP 2.10, 60.82 .28 .77 
Heart rate 2.32, 67.28 2.84 .06 
Oxygen saturation 1.85, 53.65 .65 .52 
Behavioral Pain Scale score 2.43, 70.42 4.08 .02
b
 
aMauchly’s sphericity was significant; the Greenhouse-Geisser epsilon correction is reported; 
b
Partial eta-squared was .12, suggesting a moderate effect size 
 
 
Although a downward trend in heart rate was noted, the change was not statistically 
significant (p=.06). No clinically significant changes warranting discontinuation of the 
intervention were noted in any of the physiologic variables. 
Only 5 participants had ICP monitoring devices in place at the time of study, which 
prevented statistical analysis of the values. Mean ICP values ranged from 5.8-8.8 mmHg, 
indicating normal ICP values. The lowest mean ICP was noted at T3. Cerebral perfusion pressure 
(CPP), calculated by the monitor interface, ranged from 77-81.2 mmHg, indicating normal CPP 
values. The highest mean CPP was noted at T3. 
Pain Responses to the PEP 
Mean values for the Behavioral Pain Scale scores ranged from 3.23-3.77 and were low 
(Table 6), indicating minimal presence of pain behaviors. A significant difference (Table 7) in 
the Behavioral Pain Scale scores over time were noted (F(2.43, 70.42)=4.08, p=.02). Pairwise 
comparisons showed a significant decrease in pain scores from Time 0 to Time 1 and from Time 
0 to Time 2; the decrease was sustained at Times 3 and 4. No clinically significant change 
warranting discontinuation of the intervention was noted in the Behavioral Pain Scale score. 
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Inflammatory Responses to the PEP 
Sample means, standard deviations and ranges are presented in Table 8.  
 
Table 8. Cytokine Variables 
Variable Time 0 Mean 
(SD) 
Time 3 
Mean (SD) 
Time 4 
Mean (SD) 
df
b 
F
b 
p
b 
IL-6
a 
872.33 
(1432.65) 
828.53 
(1398.69) 
763.28 
(1151.03) 
1.60, 
43.10 
4.35
a 
.03
c 
IL-10
a 
30.37 (38.23) 29.94 (38.18) 27.78 (35.34) 1.60, 
43.22 
3.03 .07 
IL-6:IL-10 
Ratio
a
 
28.82 (47.10) 28.38 (48.81) 28.31 (42.33) 1.61, 
43.38 
3.42 .05
d 
a
Log transformation; 
bMauchly’s sphericity was significant, the Greenhouse-Geisser epsilon 
correction is reported; 
c
Partial eta squared = .14, suggesting moderate effect size; 
d
Partial eta 
squared = .11, suggesting moderate effect size 
 
 
Baseline IL-6 levels in the sample ranged from 6.77-11048.9 pg/ml; only three 
participants had normal IL-6 levels (<29 pg/ml). Baseline IL-10 levels ranged from 6.46-1014.57 
pg/ml; only four participants had IL-10 levels within normal range (<10 pg/ml). No correlations 
were found between baseline IL-6 values and APACHE II scores or APACHE II predicted death 
rates. Additionally, no correlation was found between baseline IL-6 and glucose values. Extreme 
outlier values were noted in two of the participants; those participants were excluded from the 
final analysis. 
A significant difference (Table 8) in the IL-6 values over the three time periods was 
noted (F(1.60, 43.1)=4.351, p=.03). Pairwise comparisons showed a significant decrease in IL-6 
values from time 1 to time 3 but not from time 3 to time 4. No significant difference was noted in 
IL-10 values over the three time periods (Table 8). A significant effect was noted on IL-6 to IL-
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10 ratios over the three time periods (F(1.61, 43.38)=3.42, p=.05). Pairwise comparisons showed 
a significant decrease from Time 0 to Time 3 and from Time 3 to Time 4. 
Discussion 
Early delivery (X=38 hours after intubation) of the PEP was feasible, and limited only by 
the protocol-specified time frame (between 0800 and 1400) required to minimize diurnal 
variation in cytokine levels.  It is possible that the intervention could have been delivered earlier 
after mechanical ventilation if the specific time frame for cytokine specimens was not needed.  
The physiologic variables used as safety measures were readily available at the bedside and had 
direct clinical application to the participant’s care. Baseline hemoglobin values in this sample 
were low, supporting the need for a higher minimum (90% vs 88%) oxygen saturation level as a 
safety indicator.  
The intervention did not adversely change heart rate, blood pressure or oxygen saturation 
over the study period, indicating that 20 minutes of passive exercise is safe for critically ill 
patients early in the course of their illness. Only 5 (16.7%) participants had received beta-
blockers within 48 hours of the intervention, indicating that a potential increase in heart rate in 
response to activity was likely not blunted. The participant tolerance for this level of activity 
suggests that multiple episodes of passive activity in a twenty-four hour period may be tolerated 
but warrants further research. In addition, more aggressive activity, for example, greater flexion, 
more repetitions per minute or longer episodes, may also be tolerated. The CPM machines were 
deployed at the maximum rate but greater flexion degrees or longer episodes could have been 
utilized, or other options such as passive cycling could have been employed. 
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Although only 5 participants had ICP measurements, the trend of the values over time 
was interesting. ICP values stayed within normal range during and after the intervention, and the 
intervention was able to be completed without any adverse change in ICP. Values trended 
downward by the end of the intervention. Similarly, Thelanderson, Cider, and Volkmann studied 
ICP response to passive range of motion in 12 participants with parenchymal or intraventricular 
catheters and reported a decreased in ICP values from 15 mmHg to 14 mmHg after exercise.
16
 
Their findings combined with data from this indicate the need for further investigation of passive 
activity as an approach to lowering ICP in patients with critical neurological illness. This is 
especially important as previous studies have found activity to be associated with an increase in 
ICP. 
The statistical significance of the change in the Behavioral Pain Scale scores during and 
after the intervention was an unexpected finding. It may be that mobilization improves patient 
comfort level. The clinical significance of a decreased in pain score from 3.77 to 3.23 is 
unknown. However, it is important to note that pain score improvement was accompanied by a 
decrease in heart rate which supports the clinical significance of the improved pain score in this 
sample. Further, because the participants were sedated, minimal change in observed pain 
behaviors could be clinically significant.   
The high mean and wide range of baseline IL-6 levels is not an unusual finding in 
critically ill patients. This study found IL-6 levels to be much higher and IL-10 levels to be much 
lower than those reported in another study of chronically critically ill patients.
29 
However, the 
higher IL-6 and lower IL-10 values are consistent with levels in the earlier phase of illness. It is 
unusual that baseline IL-6 levels did not correlate with the APACHE II scores and predicted 
death rates, as IL-6 is considered to be a reliable indicator of illness severity.
30, 31
 It may be that 
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an injury severity measure would be a more reliable measure than APACHE II given that trauma 
patients were included in this study. Timing of the APACHE II measure in relation to study 
participation may provide additional explanation. APACHE II scores reflect the first 24 hours of 
admission, while the intervention was implemented at a mean of 38 hours after admission. IL-6 
levels have also been found to correlate with admission glucose levels, 
30, 32 
but no correlation 
was noted between baseline IL-6 and glucose levels in this study. This may be because glucose 
levels recorded for this study were obtained in proximity to the intervention, rather than at 
admission. It is likely that glycemic control would have been implemented by the time of the 
study start, at a mean of 38 hours after admission.  
The change in IL-6 levels over time was an unexpected finding. The significant change in 
IL-6 from baseline to the end of the intervention combined with the lack of significant change at 
the end of the second rest period supports not only that the PEP did not worsen inflammation, but 
it may have been responsible for a decrease in IL-6. Although IL-10 values did not change 
significantly over the three time periods, IL-6 to IL-10 ratios significantly improved from 
baseline to Time 3 and from Time 3 to Time 4. This suggests that although IL-10 values did not 
change significantly, there may have been some contribution from IL-10 increases to the ratio as 
IL-6 values did not change significantly from Time 3 to Time 4. It may be that IL-10 changes 
occur over a longer period of time than was measured in this study.  
While respiratory failure requiring intubation and mechanical ventilation was common to 
all participants, this study included participants that were commonly excluded from other 
mobilization studies. Participants included those on vasopressors, with neurologic impairment, 
intracranial pressure monitoring, open abdomen and intra-abdominal pressure monitoring, and 
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neuromuscular blockade. Inclusion of those participants supports passive exercise use in a 
broader population of patients than previously considered.  
A few limitations were identified. The intervention was delivered between 0800 and 1400 
to minimize the influence of diurnal variations on cytokine levels. Participants may be more 
fatigued and have less activity tolerance later in the day, and responses may be different if the 
intervention is delivered later. Only one episode of passive exercise was studied; it is unknown 
how repeated episodes over time will be tolerated. Attempts were made to limit patient and 
provider-initiated activity before and after the intervention, but 26.7% of participants had activity 
in the rest period before the intervention, and 56.7% had activity in the post-intervention rest 
period. While this pattern of activity reflects the care necessary in the critical care setting, it may 
have influenced results. Participant mobility level other than not being bedbound prior to 
admission was not identified and could also have influenced results.  
Implications for Practice and Research 
Findings from this study support the safety of early passive exercise in critically ill 
patients.  Nurses should consider incorporating at least 20 minutes of passive exercise early into 
the plan of care for mechanically ventilated critically ill patients so as not to miss opportunities 
to improve patient outcomes. Assessment of physiologic values that are commonly monitored in 
the critical care setting were used as safety indicators in this study and those same values can be 
readily translated into clinical practice. While this study incorporated commonly monitored 
values of heart rate, blood pressure and oxygen saturation, it may be that parameters monitored 
need to be individualized to the patient. Several study participants had additional physiologic 
monitoring to assess cardiac output, intracranial pressure (ICP), and intra-abdominal pressure, 
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and while anecdotally no changes were noted, further study is required. This is particularly 
important since these types of monitoring are commonly in use, and many mobilization protocols 
have excluded patients with these types of monitoring.
5, 13
  
While this study lends further support to safety and feasibility of passive exercise in the 
critical care setting, future research should focus on efficacy of early passive exercise within the 
context of a mobilization protocol. This study did not include patients with non-invasive positive 
pressure ventilation nor with oscillator ventilations, which are commonly used in critical care 
settings. Safety, feasibility and efficacy of passive activity should be further investigated in 
persons receiving those types of ventilatory support. 
Adaptations of passive exercise incorporated into this study should be further explored. 
Frequency may be increased from daily up to two, three or four times daily, and duration may be 
increased from 20 to 30 minutes per episode. Passive cycling devices have the capacity to 
increase duration and frequency beyond the abilities of CPM machines.
33
 Machines that provide 
axial loading and passive walking are available in rehabilitation settings, but have yet to be 
studied in the critical care setting.
34
 Comparative efficacy studies should be conducted to 
determine optimum protocols for passive activity.  
The finding that passive exercise decreased pain behaviors indicates that mobilization 
may serve as a novel approach to pain management in the critically ill patient. Future studies 
should incorporate pain responses to mobilization to attempt to replicate these findings. In 
addition, future studies should investigate whether mobilization decreases need for narcotics in 
the critical care setting. 
Although the clinical significance of changes in cytokine values obtained from these 
study participants is not known, other studies have demonstrated decreased IL-6 and increased 
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IL-10 levels over time in response to regular prescribed exercise.
35 
Further study of ongoing 
passive exercise, rather than the single episode used in this study, may provide clinical 
significance for changes in cytokines profiles in response to activity in the critically ill patient. 
Despite broader inclusion of critically ill patients in this study, many patients are still 
unable to be mobilized. Creative alternatives for those patients should be developed and 
investigated. Active arm cycling devices are available but have not yet been adapted for passive 
use.
33
 Electrical muscle stimulation may be used to produce muscle contraction without stretch 
and might be a suitable alternative to support muscle integrity in persons with spinal, pelvic or 
lower extremity fractures.
33
 Presence of an arterial or venous access device in the groin was an 
exclusion criteria for this study which may have been unnecessary. Perme found no catheter-
related complications in a study of 30 patients who sat, stood or walked with a femoral artery 
catheter in place.
36
  
 Sedation was administered to 83% of participants in this study. Practice guidelines for the 
study units dictate sedation to be adjusted to a Ramsey sedation score of 3 or better, but the mean 
GCS score for the study group was 7.8, indicating that patients may have been more deeply 
sedated.  Passive exercise was not timed with daily sedation withdrawal in this study but could 
be considered in future studies. It would also be interesting to see whether early passive exercise 
decreases delirium, agitation and the amount of sedation required in mechanically ventilated 
critically ill adults. Delirium measures were not incorporated into this study, and previous studies 
have used delirium measures only as an explanation for lack of mobilization.
5,13
 Future studies 
should incorporate delirium scales as outcome measures. 
 The mean baseline blood glucose level for this sample was elevated (149.8 mg/dl; SD 
48.7), but glucose level in response to passive exercise was not evaluated. Hyperglycemia is a 
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common consequence of critical illness, and it has a direct correlation with IL-6 levels.
32
 Activity 
is known to decrease insulin resistance and increase muscle utilization of glucose.
4,32
 It is 
possible that repeated episodes of passive exercise may not only decrease blood glucose levels 
and insulin requirements in critically ill patients, but  may decrease IL-6 levels as well. The 
relationship between mobilization, IL- 6, blood glucose levels and insulin requirements in 
critically ill patients should be explored further. 
Conclusion 
 A passive exercise protocol was well tolerated in a sample of mechanically ventilated 
critically ill participants; heart rate, mean blood pressure, and oxygen saturation remained within 
unit specified ranges throughout the study period. Behavioral Pain Scale score reductions over 
the study period indicated that passive exercise decreased pain during and after the intervention. 
Passive exercise reduced IL-6 values but further study will contribute to understanding the 
clinical significance of such reductions. Cytokine values may be useful in explaining physiologic 
reasons for benefits of mobilization in critically ill adults. 
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CHAPTER 4: METHODOLOGY 
Abstract 
The objective of this study is to identify physiologic variables that could be measured in 
response to mobilization interventions in critically ill adults.  
Physical activity may mitigate muscle damage from critical illness, but critically ill 
patients may have limited activity tolerance. Physiologic measures may be most useful in 
identifying safety and efficacy of mobilization in this population. 
A comprehensive literature search of electronic databases was conducted from 1990 to 
present, including CINAHL, MEDLINE the Cochrane Database of Systematic Reviews, and 
PubMed. Search terms used were mobilization, exercise, activity, and critical illness. Seventeen 
articles were identified for review. Physiologic measurement approaches were reviewed for 
precision and accuracy.  
Cardiopulmonary measures comprised the majority of physiologic variables identified, 
and multiple measures were used. Physiologic measures were primarily used as indicators of 
safety, although several efficacy measures were identified. Only one standardized tool was found 
that could be suitable as a safety measure, the Borg Rating of Perceived Exertion. The Medical 
Research Council Muscle Strength Grading Scale could be used as a physiologic outcome 
measure. Inflammatory biomarkers may be used as a novel measure of physiologic response. 
Descriptions of approaches to assure precision and accuracy of physiologic response measures 
were extremely limited. 
Multiple physiologic variables should be measured when considering response to 
mobilization in critically ill patients. Attention should be paid to procedures to assure accuracy 
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and precision in measurement. Future studies including physiologic measures should include 
inflammatory biomarkers, and other measures of physiologic function, such as pain assessment. 
Introduction 
Muscle weakness is a common complication of critical illness, and prevention of muscle 
weakness is a key factor in recovery from critical illness. Mobilization has been suggested as one 
intervention to mitigate muscle weakness (Lee and Higgins 2010). Mobilization activities are a 
progressive “class of interventions” (p. 22; Choi, Tasota and Hoffman 2008); interventions begin 
with passive range of motion and progress to walking, representing a wide continuum of 
activities. Many patients are unable to progress through a continuum of activities in the critical 
care, but even minimal activity may be beneficial in preventing muscle weakness. Griffiths et al. 
(1995) found that continuous passive exercise in one leg three times a day for seven days 
prevented muscle weakness in the treated leg of 5 critically ill patients. Progressive activity in 
the critical care setting has been attributed to decreased weaning time in mechanically ventilated 
patients, shorter length of stay, and improved function (Bailey et al. 2007; Bourdin et al. 2010; 
Burtin et al. 2009; Chiang et al. 2006; Morris et al. 2008; Pohlman et al. 2010; Schweickert et al. 
2009). Physical activity is also thought to reduce pain, decrease anxiety, improve delirium, 
promote sleep, and improve mood, all of which are beneficial in reducing effects of illness on 
muscle (Bailey, Miller and Clemmer 2009; Choi, Tasota and Hoffman 2008).  
Although research is beginning to substantiate the benefits of early mobilization, 
concerns exist that potential risks mitigate benefits. In healthy individuals, physiologic stress is 
an anticipated response to exercise. However, many critically ill individuals have activity 
intolerance due to their illness. Primary safety concerns are focused around activity creating 
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physiologic instability in a population that is often unstable at baseline. Stiller (2000) proposed 
monitoring physiologic responses in critically ill patients during mobilization as the guide for 
determining safety, with physiologic responses determining not only when a patient is ready to 
begin activity, but also when activity should be halted.  Physiologic responses are changes in 
measures of physiologic function. Many physiologic functions, such as heart rate, oxygen 
saturation, temperature, and blood pressure, are commonly measured by biomedical 
instrumentation in use at the bedside in the critical care setting. Physiologic function may also be 
measured directly through analysis of metabolic or cellular products in the lab setting, or 
indirectly by using tools, such as perception of exertion. Measuring physiologic responses to 
activity in critically ill patients serves as the primary measure of safety, and researchers 
interested in studying benefits of exercise in critically ill patients cannot study those benefits 
without concern for patient safety. This paper critically analyzes specific measures used to 
evaluate physiologic responses to mobilization in critically ill patients.   
Review of the Literature 
A search of the literature was conducted using the search terms, mobilization, exercise, 
activity, and critical illness to identify studies that incorporated measures of physiologic 
responses to exercise interventions; Table 1 provides operational definitions for these terms.  
CINAHL, MEDLINE, the Cochrane Database of Systematic Reviews, and PubMed 
databases were examined from 1990 to present. Studies published from 1990 forward were 
considered in an effort to reflect current practices; 165 articles were identified that met search 
criteria. To be included in the final review, articles met the following criteria: 1) published in the 
English language, 2) incorporated mobilization as an intervention in a critically ill (acute or 
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chronic) sample, and 3) utilized at least one type of physiologic measure in data collection. 
Articles excluded from the review were those that were reviews only (76 excluded), addressed 
functional or other outcomes alone, without discussion of physiologic measures (35 excluded), 
addressed mobilization after resolution of the critical illness (19 excluded), or written in a 
language other than English (19 excluded). Upon selection, articles were reviewed for types of 
physiologic measures used as well as approaches taken to assure precision and accuracy.  
Results 
Seventeen articles were found that met inclusion criteria; a summary of articles reviewed 
may be found in Table 9. 
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Table 9. Summary of Physiologic Measures Used to Evaluate Response to Mobilization. 
Author Sample and 
Setting 
Intervention Measurements* Precision and Accuracy 
Approaches 
Additional Measures 
Astorino, 
Tyerman, 
Wong, & 
Harness, 
2008 
9 spinal-cord 
injured 
participants, ages 
26-54 years 
(mean 40.6 
years); 
community 
setting 
30 minutes of 
mechanical lower 
extremity passive 
exercise, with 
incremental 
increases; repeated 
one week later 
 VO2 and VCO2 by mass 
flow sensor 
 Systolic and diastolic 
blood pressures recorded 
before, after 15 minutes, 
and immediately after 
intervention 
 Peripheral oxygen 
saturation 
 Heart rate 
 Borg Rating of 
Perceived Exertion 
(RPE) every 5 minutes 
during intervention 
 Gas analyzers calibrated 
against standard available 
precision gases; test-
retest reliability reported 
at .92 
 Manual recordings of 
blood pressure with 
recording of first and 
fourth sounds; inter-rater 
reliability reported at .98 
and .93 
 Oxygen saturation and 
heart rate measured by 
available standard 
biomedical 
instrumentation  
 Patient diary of exercise 
and diet habits the day 
before each intervention 
(to assure situations were 
as similar as possible) 
 
Chiang, 
Wang, Wu, 
Wu, & Wu, 
2006 
24 males and 8 
females; post- 
ICU, alert, 
mechanically 
ventilated; post-
ICU setting 
Participants were 
randomized to either 
physical training 
(progressive 
upper/lower 
extremity range of 
motion ROM 
exercises) or 
standard of care; 
both groups 
 Peripheral oxygen 
saturation 
 Borg Rating of 
Perceived Exertion 
(RPE) at end of 
intervention 
 Maximum morning  ET 
pressures (PImax and 
PEmax) 
 Oxygen saturation 
measured by available 
standard biomedical 
instrumentation  
 Use of standardized 
device to measure ET 
pressures 
 Standard rest period 
before ET pressure 
 Barthel Index (BI) 
and Functional 
independence 
Measure (FIM) at 
admission, and at 3 
and 6 weeks after 
admission (BI and 
FIM assessed by a 
therapist trained in 
its use) 
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Author Sample and 
Setting 
Intervention Measurements* Precision and Accuracy 
Approaches 
Additional Measures 
subjected to same 
weaning protocol 
 Upper/lower extremity 
physical strength 
measures on admission, 
at 3 and 6 weeks after 
admission 
measure; repetition of 3-5 
ET pressure measures 
with averaging of 3 
highest values 
 Strength measures 
obtained by dynamometer 
following written 
directions to standardize 
assessments; two raters 
pre-tested with 5 subjects 
to establish intra-rater 
(ICC .91) and inter-rater 
(ICC .83) reliability 
Higuchi, 
Kitamura, 
Kawashima, 
Nakazawa, 
Iwaya, & 
Yamasaki, 
2006 
7 males with 
complete 
quadriplegia, 
ages 20-34 years 
and six 
nondisabled 
males, ages 25-35 
years; community 
setting 
Machine guided 
passive leg 
movement while in 
upright position at 
preset incremental 
rates, from 20-50 
movements/minute 
 VO2, VE by mass flow 
sensor 
 Respiratory rate  
 Heart rate- recorded 
only the last 10 secs of 
each incremental stage  
 VO2/Heart Rate ratio 
calculated 
 Blood lactate via earlobe 
sample before and after 
intervention 
 Gas analyzers calibrated 
against standard available 
precision gases 
 Heart rate and respiratory 
measured by available 
standard biomedical 
instrumentation 
 Blood lactate measured 
using calibrated point of 
care lactate meter 
 Refrained from food, 
caffeine, and nicotine for 
3 hours prior to 
intervention 
 Controlled ambient 
temperature and humidity 
 
Morris, Goad, 
Thompson, 
Taylor, 
Harry, 
93 males and 72 
females, mean 
age 54 years 
received mobility 
Passive range of 
motion delivered 
three times a day by 
a trained nursing 
 Limb strength using 
Medical Research 
Council (MRC) 
 Limb strength graded by 
physical therapists who 
have demonstrated inter-
 Days to first out of 
bed 
 Ventilator days 
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Author Sample and 
Setting 
Intervention Measurements* Precision and Accuracy 
Approaches 
Additional Measures 
Passmore, et 
al., 2008 
protocol; 88 
males 77 females, 
mean age 55.4 
years received 
usual care; ICU 
setting 
assistant; five 
repetitions per joint 
examination at discharge 
 Heart rate 
 Blood pressure 
 Oxygen saturation 
rater reliability on MRC  
 Heart rate, blood pressure 
and oxygen saturation 
measured by available 
standard biomedical 
instrumentation 
 ICU length of stay 
 Hospital length of 
stay 
Muraki & 
Tsunawake, 
2008 
10 males, 10 
females; healthy; 
ages 18-22 years; 
community 
setting 
Passive leg cycling 
while seated; 
progressive increase 
from 0-70 rpm over 
30 minutes 
 VO2 and VCO2 by mass 
flow sensor 
 Muscle oxygen 
saturation using near-
infrared spectroscopy at 
precisely measured 
location  
 Continuous heart rate 
(measurement technique 
not specified) 
 
 Gas analyzers calibrated 
against standard available 
precision gases 
 Gas measurements taken 
each breath and 
calculated to average 
minute intervals 
 Muscle oxygen saturation 
collected each second and 
averaged over 30 minutes 
 Controlled ambient 
temperature and humidity 
 Threshold 
identification 
Pohlman, 
Schweickert, 
Pohlman, 
Nigos, 
Pawlik, 
Esbrook, et 
al., 2010  
49 sedated, 
mechanically 
ventilated 
participants (27 
females, 22 
males); mean age 
57.7 years (range 
36-69 years); 
ICU setting 
ROM exercises 
starting on day 1.5 
(range 1-2) after 
mechanical 
ventilation 
commenced; activity 
progressed as 
tolerated to transfer 
 Heart rate 
 Systolic blood pressure 
 Diastolic blood pressure 
 Mean blood pressure 
 Respiratory rate 
 Peripheral oxygen 
saturation 
 All above recorded at 
rest, monitored during 
activity and recorded at 
completion of 
intervention 
 All values measured by 
available standard 
biomedical 
instrumentation 
 Standardized rest period 
prior to intervention 
 Ventilator 
dysynchrony 
 Ambulation 
distance, balance 
 Ability to perform 
ADLs 
 Barthel Index (BI) 
and Functional 
independence 
Measure (FIM) on 
study entry and at 
hospital discharge 
Richard, 
Staley, & 
10 critically ill 
burn patients; 4 
Passive or active 
ROM delivered by a 
 Heart rate 
 Systolic blood pressure 
 All values measured by 
available standard 
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Author Sample and 
Setting 
Intervention Measurements* Precision and Accuracy 
Approaches 
Additional Measures 
Miller, 1994 males, 6 females; 
ages 21-80 years 
(mean 48 years); 
eight were 
mechanically 
ventilated; ICU 
setting 
physical therapist on 
mean day 13.6 
(range 2-47 days) 
after injury for mean 
duration 22.6 of 
minutes (range 15-
30 minutes) in 
supine (in bed) 
position 
 Diastolic blood pressure 
 Mean blood pressure 
 All values measured 
continuously but 
recorded before and 
after intervention 
 
biomedical 
instrumentation  
Schweickert, 
Pohlman, 
Pohlman, 
Nigos, 
Pawlik, 
Esbrook, et 
al., 2009 
104 sedated, 
mechanically 
ventilated 
participants; 29 
females, 20 males 
in intervention 
group (mean age 
57.7 years); 23 
females, 32 males 
(mean age 54.4 
years) in control 
group; ICU 
setting 
Participants 
randomized to 
exercise and 
mobilization on day 
of enrollment or 
standard of care; 
exercise started with 
10 repetitions of 
passive range of 
motion to each 
extremity/joint and 
progressed to 
transfer 
 Systolic blood pressure 
 Diastolic blood pressure 
 Mean blood pressure 
 Heart rate 
 Respiratory rate 
 Peripheral oxygen 
saturation 
 Upper/lower extremity 
physical strength 
measures using Medical 
Research Council 
(MRC) examination at 
discharge 
 Hand grip strength at 
discharge 
 Blood pressure, heart 
rate, respiratory rate, 
peripheral oxygen 
saturation measured by 
available standard 
biomedical 
instrumentation 
 Strength measures 
assessed by two 
therapists; assessment 
therapists (ATs) different 
from interventional 
therapists (ITs); ATs 
blinded from treatment 
 
 Distance walked 
independently at 
discharge 
 Hospital and ICU 
length of stay 
 Functional 
independence 
Measure (FIM) and 
Barthel Index (BI) 
at hospital 
discharge 
(Assessments 
conducted by two 
therapists; 
assessment 
therapists (ATs) 
different from 
interventional 
therapists (ITs); 
ATs blinded from 
treatment) 
Stiller, 
Phillips, & 
Lambert, 
31 (18 male, 13 
female) 
participants, ages 
Mobilization 
protocol started after 
screening for safety 
 Heart rate recording 
from a bedside monitor 
 Calculated age-predicted 
 ECG tracing satisfactory 
 Arterial lines calibrated 
daily per hospital 
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Author Sample and 
Setting 
Intervention Measurements* Precision and Accuracy 
Approaches 
Additional Measures 
2004 20-81 years 
(mean 57 years); 
ICU setting 
parameters; began 
with movement 
from lying to sitting 
position and 
progressed 
maximum heart rate 
 Systolic and diastolic 
blood pressures recorded 
from oscillometric 
sphygmomanometer or 
from bedside monitor if 
arterial line pressures 
displayed 
 Peripheral oxygen 
saturation 
 PaO2/FIO2 calculated if 
data available 
protocol 
Winkelman, 
2010 
14 females, 3 
males with acute 
COPD 
exacerbations and 
mechanical 
ventilation; ages 
35-74 (mean age 
60 years); ICU 
setting 
Observation of 
routine therapeutic 
mobility as it 
occurred; activity 
occurred for a 
minimum of 20 
minutes; activity 
consisted of passive 
range of motion with 
turning and 
progression to 
ambulation 
 Peripheral oxygen 
saturation 
 Partial pressure of 
arterial oxygen when 
available (calculated P/F 
ratio) 
 Interleukin-6 and 
Interleukin-10 at rest 
and after activity 
 Vital signs (type not 
specified) 
 Standardized period of 
observation to mitigate 
diurnal effects 
 Standardized timing for 
collection of resting and 
activity blood samples 
 Vital signs measured by 
available standard 
biomedical 
instrumentation 
 Intra-rater reliability 
established for all data 
collection points 
 Samples obtained and 
prepared for analysis by 
limited number of people 
 Samples stored at same 
temperature and analyzed 
in duplicate by same 
method throughout study  
 Duration of activity 
observed 
 Activity counts 
using an objective 
monitor  
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Author Sample and 
Setting 
Intervention Measurements* Precision and Accuracy 
Approaches 
Additional Measures 
 Sensitivity of analysis 
technique 0.5 pg/ml 
Winslow, 
White, & 
Tyler, 1990 
183 critically ill 
adults from 3 
hospital settings 
(part of a larger 
study, age range 
and gender NA) 
Turning to lateral 
position; side 
determined 
randomly in a 
standardized 
position 
 SVO2 
 Heart rate 
 Recorded every minute 
for 4 minutes 
 Standardized rest period 
prior to turning 
 Peripheral oxygen 
saturation and heart rate 
measured by available 
standard biomedical 
instrumentation 
 
Zannotti, 
Felicetti, 
Maini, & 
Fracchia, 
2003 
24 ventilator-
dependent, bed-
bound patients 
with severe end-
stage COPD; 
mean age 65.2 
years; post-ICU 
setting 
Two groups both 
received range of 
motion twice a day 
for 30 minutes; one 
group randomized to 
range of motion plus 
standardized 
electrical stimulation 
of quadriceps and 
vastus muscles for 
30 minutes twice a 
day (5 min at 8Hz 
pulses with 25 min 
of 35 Hz pulses) 
 Peripheral oxygen 
saturation 
 Heart rate 
 Respiratory rate 
 Muscle strength using 
Medical Research 
Council (MRC) 
examination at study 
onset and weekly for 
study duration 
 
 Inter-rater reliability of 
muscle strength 
 Peripheral oxygen 
saturation , heart rate and 
respiratory rate measured 
by available standard 
biomedical 
instrumentation 
 
 Number of days 
before chair 
transfer 
 Ability to be 
weaned 
*measurements are continuous unless otherwise specified 
 
Legend: COPD=chronic obstructive pulmonary disease; ECG=electrocardiogram; ET=endotracheal; FiO2=fraction of inspired oxygen; ICU=intensive care unit; 
paO2=partial arterial oxygen pressure; ROM=range of motion; SvO2=venous oxygen saturation 
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Physiologic responses were typically measured before, during and after mobilization, and 
physiologic variables were used as indicators of safety or efficacy, or both. Physiologic measures 
characteristically evaluated cardiopulmonary function but other measures were used as well 
(Table 10). Multiple rather than single measures of physiologic responses were used, and 
efficacy-focused studies incorporated both physiologic variables as well as measures of 
functional outcome.  
 
Table 10.  Description of Physiologic Measures. 
Type of Measure Description 
Heart rate Electrodes placed on the chest wall to continuously measure changes 
in electrical voltage emanating from the heart during depolarization 
and repolarization. Voltage changes are amplified and displayed on an 
oscilloscope, and converted into a numerical representation of the 
systematic depolarization and repolarization. Heart rate is calculated 
per minute as the distance between each atrial 
repolarization/ventricular depolarization event (the R-R interval). 
Blood pressure Directly measured using an indwelling arterial catheter connected to a 
transducer with a fluid interface; the arterial pressure waveform is 
displayed on an oscilloscope, and converted into a numerical 
representation. Indirectly measured by sensing arterial oscillations via 
an automated cuff; a representation of the phenomenon is converted 
into a numerical representation and displayed on the monitor. Systolic 
blood pressure (SBP) is the pressure measured in the arterial system 
during left ventricular systole, while diastolic blood pressure (DBP) is 
the pressure measured in the arterial system during left ventricular 
diastole. Mean pressure represents the average arterial pressure during 
one cardiac cycle of systole and diastole. Direct and indirect 
approaches measure systolic and diastolic pressure and often provide a 
calculation of mean pressure. 
Respiratory rate Measured by direct observation, sensor detection of movement, or 
flow-direction sensing via a breathing circuit attached to a ventilator. 
Oxygen saturation Measured by exposing hemoglobin to red and infrared light using a 
light emitting diode (LED). Oxygenated hemoglobin absorbs more 
infrared light, while non-oxygenated hemoglobin absorbs red light. As 
light passes through the hemoglobin, a light receiving diode (LRD) 
sensor calculates the percentage of each type of light and displays the 
value as a percentage; complete saturation is 100%. Pulse oximetry is 
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Type of Measure Description 
the most commonly used measure of oxygen saturation and is a 
standard monitoring technique in the critical care setting. The LED 
and LRD are placed over an accessible peripheral arterial bed, and an 
external monitor converts two wavelengths of light signal into a 
numeric display with a waveform corresponding to arterial pulsation. 
Many sites on the body may be used for sensor placement, including 
the fingertip, toe, ear lobe, tip of the nose, heel, hand, or forehead. 
Central venous oxygen saturation may be measured by an indwelling 
catheter that emits light and senses received light as blood flows past. 
The device may be placed in the jugular vein or pulmonary artery, and 
is used to calculate oxygen extraction by comparing values to arterial 
samples (thus, it is a direct measure of oxygen consumption). It is 
invasive, used only in the critical care and surgical settings (and not 
widely used even in those settings), and requires skilled personnel for 
insertion and use. Intra-arterial devices that continuously detect 
oxygen saturation are also available. 
Metabolic activity: 
oxygen consumption 
and carbon dioxide 
production 
Metabolic activity is estimated by VO2 (the difference between inhaled 
and expired oxygen concentration), as well as VCO2, (the difference 
between inhaled and expired CO2 concentration); the values are 
inversely related. The two values may be measured by a volume-
displacing or flow sensing spirometer. VO2 may also be used in 
additional calculated measures. 
Neurodynamic 
measures  
Intracranial pressure may be directly measured via a catheter placed in 
the intracranial compartment. The catheter may be placed in the 
ventricles (most common), brain parenchyma, subarachnoid or 
epidural spaces.  It is invasive, used only in the critical care settings 
and requires skilled personnel for insertion and use. Fiberoptic and 
fluid-filled systems are available. Fiberoptic systems require 
calibration prior to insertion. Fluid-filled systems require zeroing, and 
the transducer must be placed at the level of the external auditory 
meatus. Fiberoptic systems allow measurement of brain temperature 
and oxygen when intraparenchymal catheters are used. Cerebral blood 
flow is measured noninvasively using Doppler technology; flow is 
sensed by placing the probe over windows in the skull. 
 
 
Efficacy studies rarely incorporated physiologic outcome measures. Only two 
standardized tools were located that addressed physiologic responses. One, the Borg Rating of 
Perceived Exertion (RPE), represents a safety measure in this population. The other, the Medical 
Research Council (MRC) Muscle Strength Grading Scale, represents an efficacy measure. 
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Overall, descriptions of approaches to assure precision and accuracy of physiologic response 
measures were extremely limited. Discussion of specific measures used to evaluate physiologic 
responses to activity or exercise in the critical care setting and related measurement concerns 
follows. 
Specific Physiologic Measures and Measurement Concerns 
Heart Rate 
Heart rate (HR) was utilized as a determinant of safety in 12 studies (Table 11).  
 
Table 11. Parameters Used in Studies of Physiologic Responses to Mobilization. 
Parameter Studies Utilized 
Heart rate Astorino, Tyerman, Wong, & Harness, 2008; Bourdin, Barbier, Burle, 
Durante, Passante, et al., 2010; Burtin, Clerckx, Robbeets, Ferdinande, 
Langer, et al., 2009; Clini, Crisafulli, Antoni, Beneventi, Trianni, Costi, 
et al., 2011; Higuchi, Kitamura, Kawashima, Nakazawa, Iwaya, & 
Yamasaki, 2006; Morris, Goad, Thompson, Taylor, Harry, Passmore, et 
al., 2008; Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et 
al., 2010; Richard, Staley, & Miller, 1994; Schweickert, Pohlman, 
Pohlman, Nigos, Pawlik, Esbrook, et al., 2009; Stiller, Phillips, & 
Lambert, 2004; Thelandersson, Cider, & Volkmann, 2010; Winslow, 
White, & Tyler, 1990; Zannotti, Felicetti, Maini, & Fracchia, 2003 
Blood pressure 
 
Systolic and Diastolic: Astorino, Tyerman, Wong, & Harness, 2008; 
Burtin, Clerckx, Robbeets, Ferdinande, Langer, et al., 2009; Stiller, 
Phillips, & Lambert, 2004 
 
Systolic, Diastolic and Mean: Pohlman, Schweickert, Pohlman, Nigos, 
Pawlik, Esbrook, et al., 2010; Richard, Staley, & Miller, 1994; 
Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et al., 2009 
 
Mean only: Bourdin, Barbier, Burle, Durante, Passante, et al., 2010 
 
Not specified: Bailey, Thompsen, Spuhler, Blair, Jewkes, Bezdjian, et al., 
2007; Clini, Crisafulli, Antoni, Beneventi, Trianni, Costi, et al., 2011; 
Morris, Goad, Thompson, Taylor, Harry, Passmore, et al., 2008; 
Thelandersson, Cider, & Volkmann, 2010 
Respiratory rate Bourdin, Barbier, Burle, Durante, Passante, et al., 2010; Burtin, Clerckx, 
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Parameter Studies Utilized 
Robbeets, Ferdinande, Langer, et al., 2009; Higuchi, Kitamura, 
Kawashima, Nakazawa, Iwaya, & Yamasaki, 2006; Pohlman, 
Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et al., 2010; 
Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et al., 2009; 
Zannotti, Felicetti, Maini, & Fracchia, 2003 
Oxygen saturation Peripheral oxygen saturation: Astorino, Tyerman, Wong, & Harness, 
2008; Bailey, Thompsen, Spuhler, Blair, Jewkes, Bezdjian, et al., 2007; 
Bourdin, Barbier, Burle, Durante, Passante, et al., 2010; Burtin, Clerckx, 
Robbeets, Ferdinande, Langer, et al., 2009; Chiang, Wang, Wu, Wu, & 
Wu, 2006; Clini, Crisafulli, Antoni, Beneventi, Trianni, Costi, et al., 
2011; Morris, Goad, Thompson, Taylor, Harry, Passmore, et al., 2008; 
Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et al., 2010; 
Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et al., 2009; 
Stiller, Phillips, & Lambert, 2004; Winkelman, 2010; Zannotti, Felicetti, 
Maini, & Fracchia, 2003 
 
Central venous oxygen saturation: Winslow, White, & Tyler, 1990 
Metabolic activity VO2/VCO2: Astorino, Tyerman, Wong, & Harness, 2008; Higuchi, 
Kitamura, Kawashima, Nakazawa, Iwaya, & Yamasaki, 2006 
Neurodynamic 
parameters 
Thelandersson, Cider, & Volkmann, 2010 
Cytokines Winkelman, Higgins, Chen, & Levine, 2007; Winkelman, 2010 
Others 
 
Borg RPE: Astorino, Tyerman, Wong, & Harness, 2008; Chiang, Wang, 
Wu, Wu, & Wu, 2006 
 
Airway pressures: Chiang, Wang, Wu, Wu, & Wu, 2006; Clini, 
Crisafulli, Antoni, Beneventi, Trianni, Costi, et al., 2011 
 
Muscle strength measures: Chiang, Wang, Wu, Wu, & Wu, 2006; Clini, 
Crisafulli, Antoni, Beneventi, Trianni, Costi, et al., 2011; Morris, Goad, 
Thompson, Taylor, Harry, Passmore, et al., 2008; Schweickert, Pohlman, 
Pohlman, Nigos, Pawlik, Esbrook, et al., 2009; Zannotti, Felicetti, Maini, 
& Fracchia, 2003 
 
CAM-ICU:  Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook, et 
al., 2010; Schweickert, Pohlman, Pohlman, Nigos, Pawlik, Esbrook, et 
al., 2009 
 
 
Heart rate was measured by a five-lead electrocardiogram (ECG). This measure was 
commonly available at the bedside, or included as part of a measurement cart. Although increase 
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in heart rate (achievement of a target heart rate) is a desired outcome with exercise, an increase 
in heart rate carried a different significance in critical care, and was considered an adverse or 
detrimental response. No studies mentioned acceptable heart rate ranges, and only one study 
mentioned a specific percent increase in HR (Richard, Staley and Miller 1994). In order to 
address clinical significance of heart rate change in this setting, the definitions of an acceptable 
or unacceptable heart rate should be addressed. An unstable heart rate may be defined as outside 
of accepted parameters (i.e., above or below 60-100/minute), or a percentage increase above 
baseline.  
Heart rate measures should be timed to capture responses as they occur. Timing was 
routinely specified as before (at baseline) and after (upon completion but no longer term) an 
intervention. Several studies included measures during the intervention as well, but time points 
varied. For example, Higuchi et al. (2006) measured heart rate for 10 seconds before each change 
in passive exercise level. Consideration must be given to timing intervals so as to capture 
optimum data reflective of the phenomenon of study.  
Heart rate alone may be an insufficient measure of cardiac response to mobilization. 
Cardiac arrhythmias may be detected on continuous 5-lead ECG monitoring during activity, but 
5-lead ECGs may be otherwise limited in the information they supply. If concerns exist about the 
passive exercise creating cardiac ischemia, 12-lead or ST-segment monitoring may be more 
appropriate measures. Although these monitoring options are available at the bedside, none of 
the studies reviewed utilized these advanced forms of monitoring.  
Precision and accuracy of HR data depends on standard lead placement. No study 
identified that standard lead placement was considered. Further, monitoring devices vary in 
accuracy and precision, and these data were rarely reported. Manufacturer reports of accuracy 
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and precision should be considered when using bedside monitoring data for variable 
measurement. One last concern is that many extraneous factors, particularly medications, may 
influence heart rate. For example, for patients receiving beta-adrenergic antagonists, 
tachydysrhythmias may absent as an indicator of activity intolerance.  
Blood Pressure 
Blood pressure (BP) was measured in eleven of the seventeen studies as a safety measure 
(Table 11). The method of measurement (direct vs indirect) was specified in five of the nine 
studies. Both measures are available in the critical care setting. One study used an auscultated 
method, listening to the first and fourth Korotkoff’s sounds as the BP measure (Astorino et al. 
2008). This measure is subject to the individual’s hearing acuity and speed of recognition and is 
infrequently used in the critical care setting. 
Three different blood pressure values are possible: systolic, diastolic and mean. All three 
values are readily available in the critical care setting. Of the 10 studies reporting blood pressure 
values, 3 reported systolic and diastolic values only, 3 reported systolic, diastolic and mean 
values, one reported mean pressure only, and 3 did not specify blood pressure value measured. 
Consideration should be given to which of the three values is most appropriate for the purpose of 
measurement. It may be that diastolic pressure is of greatest importance since it represents the 
baseline pressure against which the heart needs to pump. Astorino et al. (2008) indicated that 
diastolic pressure was the most significant BP measure of safety during mobilization.  
Timing of measurement is a concern. The direct method allows for continuous measure 
and display of BP values, while the indirect method can provide values as frequently as every 
minute. Timing in studies reviewed was routinely specified as before (baseline), during (at 
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specified intervals), and after (upon completion but not longer term) an intervention. For 
example, Pohlman et al. (2010) used continuous direct BP measures to cross all three time 
frames, while Stiller et al. (2004) measured BP indirectly in between activity tasks. Further 
considerations in choice of BP method relate to availability and invasiveness. Several researchers 
mentioned use of whichever BP method was available at the bedside (Schweickert et al. 2009; 
Winkelman 2010). The invasive nature of the direct approach to BP measurement may not be 
warranted when precision and accuracy of the indirect method can be assured. However, 
repeated cuff measurement can produce pain-induced physiologic changes which may also affect 
accuracy of the BP measure. 
Precision and accuracy of BP data depend on standard arm and cuff placements and 
appropriate sizing for the indirect method or proper transducer placement (at the phlebostatic 
axis) for direct measurement. Further, the direct method requires zeroing against atmospheric 
pressure. No study in this review identified that standard placements or zeroing were considered. 
Monitoring devices vary in accuracy and precision, and similar to heart rate, researchers referred 
readers to manufacturer sources for precision and accuracy data. Patient condition or medication 
may alter vascular tone and resistance to flow, and should be considered when interpreting the 
clinical significance of BP values. Schweickert et al. (2009) identified vasoactive medications 
used but did not relate these to BP measures.  
Respiratory Rate 
Respiratory rate (breaths per minute) was measured in six of the 17 studies (Table 11); 
methods for measuring respiratory rate were not specified in those studies. The myriad 
influences on respiratory rate render this parameter the least precise measure of response to 
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activity, and likely account for the less frequent use of this measure in studies. Bourdin et al. 
(2010) used respiratory rate as a safety measure, finding that rate increased with walking and arm 
exercise but not with other activities; increase in respiratory rate did not result in stopping the 
exercise activity nor did it contribute to adverse events.  
A respiratory lead attached to the chest wall senses movement with inspiration and 
expiration. Lead placement, depth of respirations, and body habitus determine accuracy of this 
approach. The flow-sensing technology in a ventilator has been calibrated by the manufacturer 
against a standard and provides the greatest precision and accuracy for this measure. However, 
even with flow-sensing technology, critically ill patients that are paralyzed or sedated and on a 
controlled mode of ventilation are unlikely to demonstrate change in respiratory rate. 
Oxygen Saturation  
Twelve of the 17 studies reviewed included peripheral oxygen saturation via pulse 
oximetry as a physiologic measure (Table 11). Pulse oximetry is the most commonly used 
measure of oxygen saturation and is a standard monitoring technique in the critical care setting. 
Central venous oxygen saturation was reported in only one of the studies (Winslow, White & 
Tyler, 1990); this approach is invasive and infrequently used in the critical care setting. Muscle 
oxygen saturation has been used as a physiologic measure in exercise studies Muraki and 
Tsunawake 2008), but this measure provides only a focal measure of oxygen saturation, is 
invasive, and not readily available in critical care settings. 
Precise and accurate peripheral oxygen saturation values require standard placement of 
the LED/LRD sensor, but given the placement options, can vary widely. An adequate waveform 
suggests an adequate sample for testing; oxygen saturation values are inaccurate when arterial 
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pulsations are not detected. Interpretation of values also requires knowledge of hemoglobin 
level; low hemoglobin levels may artificially inflate saturation. Additionally, any factor that 
affects peripheral blood flow in the region of measurement can provide inaccurate values. 
Examples include systemic vasoconstriction due to disease, drugs, or body temperature. None of 
the studies addressed sensor placement, hemoglobin values, confounding factors or waveform 
adequacy.  The threshold for desaturation was described in 4 reports (Bailey et al. 2007; Burtin et 
al. 2009; Pohlman et al. 2010; Schweickert at al. 2009), and varied from <80% to <90%, with no 
mention of consideration of hemoglobin values.  Monitoring devices also vary in accuracy and 
precision, and researchers consistently referred readers to manufacturer sources for precision and 
accuracy data. 
Oxygen Consumption and Carbon Dioxide Production 
VO2 (the difference between inhaled and expired oxygen concentration), as well as 
VCO2, (the difference between inhaled and expired CO2 concentration) were reported measures 
in 2 studies (Astorino et al. 2008; Higuchi et al. 2006). Flow-sensing spirometry was used, and 
precision was determined by calibration against precision gases. Specific protocols were 
implemented to standardize timing of measurement in relation to intervention, and ambient 
temperature and humidity were controlled to improve precision (Astorino et al. 2008; Higuchi et 
al. 2006). Ventilators used in this setting often have built in flow sensors that have the capability 
to provide continuous feedback of ventilatory measures, and if available, could be used. 
However, these measures do not reflect daily practice. To assure precision and accuracy, 
ventilators are calibrated by the manufacturer against standard precision gases and periodically 
during use in the same manner per manufacturer guidelines. In the critical care setting, pressure 
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support and volume controls may alter these values and must be considered when interpreting the 
values. Ventilator parameters should not be changed during measurement periods where 
possible. Bailey et al. (2007) described increasing FiO2 by 0.2 prior to mobilization as a pre-
emptive approach.   
Neurodynamic Parameters 
Intracranial pressure (ICP) and cerebral blood flow (CBF) are two neurodynamic 
parameters routinely used in patients with critical neurologic illness. Only one study was found 
that measured neurodynamic parameters. Thelandersson, Cider and Volkmann (2010) directly 
measured ICP via a ventricular catheter, and indirectly measured CBF using transcranial 
Doppler.  ICP monitoring is invasive, and CBF measured by transcranial Doppler is noninvasive. 
Invasive measures of CBF are available but infrequently used in clinical settings. 
 Accuracy and precision of ICP are dependent on transducer placement and stopcock direction if 
a drainage system is used. The monitoring system was not specified, but may require calibration 
prior to insertion, or zeroing if a fluid interface is used. Accuracy and precision of transcranial 
Doppler measurement of CBF is dependent on practitioner training as well as device standards 
determined by the manufacturer. 
Inflammatory Markers 
Critical illness has been associated with inflammation (Winkelman, Higgins, Chen, & 
Levine 2007), and exercise has been reported to both increase and decrease inflammation (Sari-
Sarraf, Reilly, & Doran, 2006). This suggests that inflammatory markers may be useful in 
identifying both beneficial and adverse responses to activity in critically ill patients. Cytokine 
levels have been used as an in vitro indicator of inflammation, marking illness severity as well as 
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a response to therapeutic interventions. Cytokine sample must be obtained in a precise manner if 
it is to be an accurate marker. Specific approaches that enhance precision and accuracy of 
cytokine values obtained are (Zhou et al. 2010):  
 Obtaining the sample from the appropriate source. Cytokines may be found in many bodily 
fluids and tissues, such as blood, breast milk, urine, and saliva (Sari-Sarraf, Reilly and Doran 
2006). Natural cytokine levels may differ in each of these areas, so consideration must be 
given to using the correct source. Blood provides the optimum systemic measures of cytokine 
activity, but salivary samples may be considered because they are more easily obtained. 
 Obtaining the sample at the appropriate time. Diurnal influences may cause cytokine levels to 
differ by time to day. Obtaining samples at a consistent time of day is important in sample 
reliability.  
 Limiting extraneous influences on cytokine levels. Activity, especially seizures, agitation and 
shivering can alter cytokine levels. Care should be taken to control activity to the extent 
possible or provide a period of rest before sampling to assure reliability. Feedings and lipids 
can also increase cytokine levels. Sampling should be timed during a fast for accuracy; if 
fasting samples are not possible, then the influence of feeding on cytokine level should be 
taken into consideration. 
 Obtaining the sample in the appropriate manner. No evidence was found of any difference 
between arterial and venous cytokine levels, but a needle stick or venous catheter may invoke 
a local inflammatory response. Use of existing arterial or venous access devices may 
eliminate this influence. It is also important to obtain the appropriate amount of sample, 
usually a minimum of 3 ml. 
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 Preparing and storing the sample appropriately. Cytokines degrade soon after a sample is 
obtained, and should be prepared immediately after a draw. The blood sample is centrifuged, 
and serum is removed and frozen at -80
o
C until analyzed. 
 Analyzing the samples in the most beneficial manner. Multiplex arrays allow analysis of 
cytokine interactions rather than providing simple levels as ELISA measures do.  
Winkelman (2010) collected blood samples for IL-6 and IL-10 immediately before and after a 20 
minute activity period. Samples were obtained from existing venous or arterial access, aliquoted 
and frozen according to a specific protocol, and analyzed in duplicate for accuracy using 
established detection limits and sensitivity of 0.5pg/ml. In a related study, Winkelman, Higgins, 
Chen, and Levine (2007) used an ELISA analysis with predetermined sensitivity and precision. 
Other Measures 
Borg Rating of Perceived Exertion  
Perceived exertion is often used as a compare measure to physiologic responses in 
exercise studies. Two of the 17 studies used the Borg Rating of Perceived Exertion (RPE) scale 
in studies of physiologic responses to mobilization (Astorino et al. 2008; Chiang et al. 2006). 
The Borg RPE (Table 12) was initially developed in 1970, with the intention of using it as a 
proxy measure of intensity in research studies evaluating exertion during exercise (Borg 1970).  
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Table 12. Borg Rating of Perceived Exertion (Chen, Fan, and Moe 2002).  
Score Verbal Anchor 
6 No exertion at all 
7 Extremely light 
8  
9 Very light 
10  
11 Light 
12  
13 Somewhat hard 
14  
15 Hard (heavy) 
16  
17 Very hard 
18  
19 Extremely hard 
20 Maximal exertion 
 
Therapeutic exercise has three domains: duration, intensity and frequency. Intensity is the 
most subjective domain, and the Borg RPE was developed as an attempt to quantify this domain 
in relation to physiologic variables. It was normed in healthy adult males exercising to 
exhaustion on a cycle ergometer. The unidimensional scale has numeric ratings from 6 to 20 with 
verbal anchors along the scale that are purported to indicate sequentially increasing exercise 
intensity. The scale range corresponds to one-tenth of the heart rate. Numeric values were added 
to render the tool less subject to psychological variables impacting perceived exertion. Initial 
work revealed strong correlations between heart rate and the Borg RPE. One concern with the 
scale is that the verbal anchors of numerical values imply interval level data when the data is 
actually categorical. Yet, Dawes (2010) found good agreement between verbal anchors and 
numerical values with intra-class correlations of .96-.98, and box plots showed a sigmoid shaped 
curve which corresponded with differences in ratings. Criterion-related validity has been 
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reported at .8-.9, but a recent meta-analysis of 164 studies using the RPE showed validity 
coefficients in the .5-.6 range (Chen, Fan and Moe 2002). Concurrent validity, test-retest 
reliability, and sensitivity have been demonstrated in numerous additional studies. Since the 
introduction of the RPE, two important adaptations have occurred. One is the CR-10, which is 
uses the same verbal anchors as the RPE but rates exertion on a 0-10 scale. The other uses the 6-
20 scale but substitutes breathing-related exertion anchors. Contemporary use is more common 
in fitness rather than research settings, although it has been used in studies of COPD patients 
(Scott 2004). 
There are several limitations to use of the tool that deserve mention. Since the tool was 
normed in a healthy population on cycle ergometry, it should be re-evaluated in other 
populations using other exercise approaches. Dawes, et al. (2010) found that brain-injured 
persons were unable to clearly distinguish anchor differences, which is not surprising since tool 
completion requires cognitive appraisal which may be dampened in individuals with brain injury. 
Age extremes present similar challenges, with decreased reliability noted in younger children 
and older adults. As with many tools, reliability decreases when scores lie at either end of a tool. 
Lower correlations have been found when the RPE is compared to physiologic changes other 
than heart rate, such as lactate levels or muscle oximetry. One last concern relates to sensitivity 
and reliability. Grant et al. (1999) found that Borg RPE demonstrated lower sensitivity to change 
than the visual analogue equivalent, but greater sensitivity when used as a measure of fatigue.  
The RPE would be challenging to use in the study of physiologic responses to passive 
exercise in critically ill population for several reasons. First, minimal exercise is the goal of 
mobilization in this population, and scale reliability is lower at this end of the scale. Second, the 
population of critically ill adults tends to be older in age, and reliability has been found to be 
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lower in older adults (Groslambert and Mahon 2006). Further, with cardiac and other 
hemodynamic monitoring being the norm in this setting, it is not necessary to use a proxy 
measure of exertion. Last, the cognitive appraisal required for scale completion may be lacking 
in study participants because of factors such as illness severity, and concomitant use of pain 
medication and sedation. 
Muscle Strength  
Comparative muscle strength has been used as a measure in mobilization studies. Five 
studies of passive exercise incorporated muscle strength as an outcome measure (Zannotti et al. 
2003; Chiang et al. 2006; Morris et al. 2008; Schweickert et al. 2009; Clini et al 2011). Several 
different approaches to measurement were used. Use of a dynamometer to measure strength is 
considered the gold standard of strength measurement (Paternostro-Sluga et al. 2008) but only 
two of the studies used this device as a strength measure, and grip strength of hand muscles was 
the sole measure. A dynamometer measures muscle strength against a strain-gauge applied 
resistance, and devices such as this are not portable and consequently, not readily available in the 
critical care setting. Accuracy of dynamometer measures is dependent on manufacturer 
standards, but also depends on a consistent position of the extremity measured (Chiang et al. 
2006). Repeated measures should be obtained and averaged; adequate time between measures 
should be allowed to minimize the effect of fatigue on the muscle. 
Manual muscle testing (MMT) was used most commonly to measure strength as an 
outcome in the studies; it involves strength assessments by an experienced observer who 
evaluates muscle strength against the examiner’s resistance. The examiner then scores the 
 100 
strength assessed on the 0-5 Medical Research Council (MRC) Muscle Strength Grading Scale 
(Table 13).  
 
Table 13. Medical Research Council Muscle Strength Grading Scale (Paternostro-Sluga, et al. 
2008). 
Rating Observation 
0 No muscle contraction is detected. 
1 A trace contraction is noted in the muscle upon palpation  
2 Active movement when gravity is eliminated 
3 Active movement against gravity but not resistance 
4 Active movement against some resistance 
5 Active movement to overcome resistance 
 
  
The MRC scale was developed in 1976 as a way to standardize muscle assessments for 
studies that used muscle strength as an outcome measure. A modified MRC (Paternostro-Sluga et 
al. 2008) has been developed which considers range of motion in addition to strength in the 
assessments. Inter-rater and intra-rater reliability have been established in a number of studies 
(Paternostro-Sluga et al. 2008). Reliability is greatest at the scale ends (0 and 5) while reliability 
between scores of 3 and 4 is weakest. MRC scale ratings are dependent on examiner expertise as 
well as patient cooperation. To assure reliability of strength measures obtained, the examiner 
must be appropriately trained, have inter-rater and intra-rater reliability established, and take 
action to assure patient cooperation. Morris et al (2008) established inter-rater reliability among 
therapists using the MRC scale for their study, and used therapists performing muscle strength 
assessments were blinded to the protocol arm as measures of precision and accuracy. 
One unique muscle strength measure found relates to airway pressures. Chiang et al. 
(2006) and Clini et al. (2011) used maximum inspiratory and expiratory pressures as a strength 
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outcome measure. To assure reliability of measures obtained, the patients were suctioned before 
measurement, seated at 45
o
 head of bed elevation, and instructed to maximally inhale then 
exhale. Tracheostomy cuff pressures were checked to eliminate the influence of a possible leak, 
and a single standardized manometer was used by a single examiner to measure 3-5 pressures 
each, which were averaged (Chiang et al. 2006). While this standardized approach can provide a 
reliable measure of respiratory muscle strength, it does require patient cooperation which can be 
a limitation in the critical care setting. 
Discussion and Recommendations 
While purpose of measurement guides the specific approach chosen, the setting of the 
population of interest determines to a large degree what is possible to measure and how measures 
can best be obtained. Responses to passive exercise in the critical care setting are best measured 
by cardiopulmonary physiologic variables for several reasons. These variables are reflective of 
the type of metabolic activity that exercise produces and translatable across studies. In addition, 
physiologic variables are not only readily available in the critical care setting, but those variables 
also represent an important safety parameter which can be crucial in the conduct of research in 
this setting. Safety of any intervention must be established before efficacy can be demonstrated. 
Additional physiologic measures, such as muscle biopsy and electromyography could be 
considered when the primary focus is on outcomes of mobilization. However, other less invasive 
outcome measures, such as walking distance and grip strength, are available. 
Measurement of multiple physiologic variables should be considered where possible. In 
this review, no study used just a single measure of physiologic response to passive exercise. 
Multiple measures of the same construct improve reliability as well as validity (Waltz, Strickland 
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and Lenz 2010). In the critical are setting, use of multiple measures may decrease the influence 
of extraneous factors on the measures obtained. Although one tool (the Borg RPE) is available as 
a substitute measure for physiologic variables, its substantial limitations in the setting render the 
measure less useful than more direct measures of physiologic response.  
Noticeably lacking were measures related to comfort, anxiety, mood, and sleep outcomes 
related to mobilization. Pain is routinely assessed in critically care settings using valid and 
reliable tools for patients unable to verbally indicate pain, such as the Behavioral Pain Scale 
(Payen et al. 2001). Two studies in this review included the Confusion Assessment Method for 
the Intensive Care Unit (CAM-ICU) as a delirium measure (Schweickert, Pohlman, Pohlman, 
Nigos, Pawlik, Esbrook, et al., 2009; Pohlman, Schweickert, Pohlman, Nigos, Pawlik, Esbrook, 
et al., 2010). Pohlman, et al. (2010) used the CAM-ICU to explain lack of activity progression, 
while Schweickert, et al. (2009) identified fewer CAM-ICU positive days with exercise. This 
tool has established reliability and validity in mechanically ventilated and critically ill patients, 
and could be considered as an important measure of cognitive response in mobilization studies. 
Additional measures of sleep and mood could be considered as significant physiologic outcome 
measures in future mobilization studies. 
Measurement of some physiologic variables can be invasive, and an invasive device does 
not always guarantee greater precision or accuracy. The need for precision and accuracy must be 
balanced against the invasiveness of the measurement device. Access is another concern. Most 
studies of physiologic variables in the critical care setting capitalize on available monitoring, and 
give secondary consideration to invasiveness, precision and accuracy.  
Little mention was made in the studies of procedures taken to assure accuracy and 
precision when measuring physiologic variables using available monitoring equipment. 
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Researchers must become very familiar with the proper use of biomedical instrumentation at the 
bedside in the critical care setting to enhance accuracy and precision. Consulting manufacturer 
data about methods using to determine sensitivity, specificity, error rates, and other precision 
data is essential if the instrumentation is to provide reliable and valid measures of physiologic 
data. Further, devices must be utilized in the same manner for each measure, and according to 
manufacturer guidelines. These are perhaps the greatest obstacles to accurate and precise 
measurement in the clinical setting. 
Timing of physiologic measures was consistently identified as before, during, and after 
the exercise intervention in this review, but specific time frames beyond that were variable. 
Variable timing of measures renders comparisons between studies difficult. Timing of 
measurements can be challenging, as it may be difficult to identify the best time to capture a 
specific phenomenon. Many of the physiologic variables utilized were continuously displayed or 
multiple measures taken and averaged over time. Clearly, if physiologic variables are to be used 
in research studies, extensive consideration should be given to timing of those observations.  
No mention was made in the studies reviewed of other physiologic variables that can be 
measured in the clinical setting that may be affected by passive exercise. For example, 
temperature can increase in response to exercise, but it was not mentioned as a variable in any of 
the studies. Interestingly, one of the studies reviewed mentioned control of ambient temperature 
as an important procedure for assuring reliability of other physiologic measures (Higuchi et al. 
2006). Temperature is another physiologic measure that is readily available at the bedside in 
critical care setting, but is subject to the same concerns as other physiologic measures using 
existing biomedical instrumentation. Consideration should be given to technique (tympanic, oral, 
 104 
or core measures) timing of the measurement, and precision and accuracy of the measurement 
device.  
Mobilization study criteria often excluded participants with neurological problems, and 
only one study (Thelandersson, Cider & Volkmann 2010) was found that measured 
neurodynamic responses to passive exercise. Further study of intracranial pressure and cerebral 
blood flow responses to passive exercise is necessary before excluding study participants with 
neurologic problems. Of note is that Thelandersson, Cider and Volkmann (2010) found no 
change in ICP during passive exercise, and ICP significantly decreased after passive exercise, 
suggesting that activity may improve neurodynamic values. Muscle blood flow is known to 
increase during activity, yet no study to date has directly measured muscle blood flow, although 
one study was found that measured an analogue, that of muscle oxygen saturation, but in healthy 
adults (Muraki and Tsunawake 2008). Future studies may consider measurement of additional 
variables to better understand outcomes. 
Physiologic measures were used infrequently as outcome measures in studies reviewed, 
unless the study outcome focused on safety. Further, in studies evaluating efficacy of passive 
exercise, no connection was made between physiologic variables and outcomes. It would 
interesting to evaluate whether patients receiving passive or progressive exercise in the critical 
care setting actually have improved physiologic parameters (lower resting heart rate or greater 
heart rate and blood pressure variability, indicating better vascular tone) in addition to looking at 
just functional outcome measures.  
Cytokines are the only physiologic variables found in this review that can be identified as 
both an outcome measure and a safety measure, and only two studies identified use of cytokine 
levels as a physiologic variable to be evaluated in response to mobilization in critically ill adults. 
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Understanding of the contribution of inflammation to muscle damage is rapidly evolving.  Future 
studies should include inflammatory biomarker measurements as they may be more accurate 
measures of the true physiologic response to exercise in the critically ill than the 
cardiopulmonary measures consistently found in this literature review.  
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APPENDIX A: BLOOD SAMPLING PROTOCOL 
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1. Assess patency of existing arterial or venous access device prior to study start. 
2. For venous access, swab port for 15 seconds with alcohol swab. Place a 10 ml syringe on 
the port and withdraw 2 ml for discard. Swab port again for 15 seconds with alcohol 
swab. Place a new 10ml syringe onto the port and withdraw 3ml blood. Swab port for 15 
seconds again with alcohol swab. Flush per protocol (2-5 ml in a 10 ml syringe, 
depending on device).  Transfer sample into a 5 ml green top tube and place on ice. Label 
the specimen with the de-identified participant identification code. 
3. For arterial access, remove yellow cap (while turned off to the cap) and place a 3 ml 
syringe to stopcock. Turn the stopcock and withdraw 2 ml for discard. Return stopcock to 
off position. Place a new 3ml syringe over the stopcock. Turn the stopcock and withdraw 
3ml blood. . Return stopcock to off position. Replace the yellow cap and flush per 
protocol. Transfer sample into a 5 ml green top tube and place on ice. Label the specimen 
with the de-identified participant identification code. 
4. Once blood specimen is obtained, allow it to clot for 20 minutes, then centrifuge for 20 
minutes at 4
o
C, at 1000g. Aliquot the serum and freeze in a -80
o
C freezer. (Specimens 
will be stored in a research freezer at Orlando Regional Medical Center.) 
5. Serum cytokine levels will be analyzed collectively after completion of enrollment and 
intervention. Analysis will be conducted using ELISA in the Research Laboratory at 
Orlando Health Corporate Medical Education, Research and Training Center, under the 
direction of Dr. Ewa Jaruga-Killeen. 
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